{"FinancialColumns":null,"FinancialHits":null,"TotalStockCount":0,"Securities":null,"OtcSecurities":null,"SortedSecurityCodes":null,"SearchId":"575d5cf2-5473-4c7f-b8e8-6e5aab24f29b","TotalCompanyCardCount":111,"Total":164,"Took":384,"DbTook":0,"Hits":[{"Id":"52720753","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ZqSbJ53aqobGxgQFZMj62Q==","EncryptionKey":"WnFTYko1M2Fxb2JHeGdRRlpNajYyUT09","Title":"香雪制药：2019年年度报告摘要（更新后）","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-07-22T00:00:00","StockCode":"300147","StockTicker":"香雪制药","Url":"http://static.cninfo.com.cn/finalpage/2020-07-22/1208059658.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=nr3MZWybcGEf2a1JoEzyxRQjub2OGMjGyHcxD2KMC2L4EGapPpA0QQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300147/2020-07-22 2019年年度报告摘要（更新后）.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300147 \t证券简称：香雪制药\t公告编号：2020-046<br />&emsp;&emsp;广州市香雪制药股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />&emsp;&emsp;本公司董事会..."},"Highlight":{"Content":["@6@63@设施标准、管理规范、特色鲜明的道地药材生产基地，培育一批创新力强、规模大的中药企业集团，创响一批有信誉、有影响的中药知名品牌，努力提升中药材质量效益和产业竞争力”；《中医药发展“十三五”规划》：“促进中药材种植养殖业绿色发展”；《中医药健康服务发展规划（2015-2020年）》明确提出：“大力实施中药材生产质量管理规范（GAP），扩大中药材种植和贸易”；《国务院办公厅关于促进医药产业健康发展的意见》：“促进中药资源可持续发展，加强对中药资源的保护、研究开发和合理利用”；《“<em>健康中国2030</em>”规划纲要》：“加强中药新药创新能力建设，大力发展优质中药，健全质量标准体系，提升质量控制技术，实施绿色和智能改造升级”。国际、国内对中医药的发展日益重视，中医药的国际化发展获得了更多的空间。","@6@64@&emsp;&emsp;随着中国人口老龄化不断加深和《“<em>健康中国2030</em>”规划纲要》的制定，预计到2020年，中国健康产业产值将达到8万亿，到2030年达到16万亿元，成为国民经济的支柱性产业。根据国务院新闻办发布的《中国的中医药》白皮书，至2020年，我国中医药大健康产业将突破3万亿，年均复合增长率将保持在20%。随着居民消费水平的提高，更多人民群众开始关注养生保健，各类中成药需求在不断增大，未来我国中医药行业具有强大的潜在发展空间。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"52720752","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"tPJa3WyGbvFEkHfH2DD6WQ==","EncryptionKey":"dFBKYTNXeUdidkZFa0hmSDJERDZXUT09","Title":"香雪制药：2019年年度报告（更新后）","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-07-22T00:00:00","StockCode":"300147","StockTicker":"香雪制药","Url":"http://static.cninfo.com.cn/finalpage/2020-07-22/1208059659.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=cTHLjVz6FDCbXSwu01lDZXR2A0DgPBrZq+r1ZPe26ZtfsDdy9Srcyg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300147/2020-07-22 2019年年度报告（更新后）.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;广州市香雪制药股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />广州市香雪制药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;20\u000020\u0000-\u00000\u000045\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 05 \u0000 月 \u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>","<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"52432174","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"PoJBN+UHEAZj48zWEc9exw==","EncryptionKey":"UG9KQk4rVUhFQVpqNDh6V0VjOWV4dz09","Title":"*ST济堂：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-06-30T00:00:00","StockCode":"600090","StockTicker":"*ST济堂","Url":"http://static.cninfo.com.cn/finalpage/2020-06-30/1207969799.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=06PxzJgluL+yUpLADv0ZJ6N8bqN6LAz4G53UTDvrAnsy6da8C8Ufog==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600090/2020-06-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600090 \u0000 \u0000 公司简称：\u0000 同济堂\u0000<br />新疆同济堂健康产业股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000168\u0000<br />"},"Highlight":{"Content":["在《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"52432193","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"EcsE2B2AZ70QeYQVtDTxYA==","EncryptionKey":"RWNzRTJCMkFaNzBRZVlRVnREVHhZQT09","Title":"*ST济堂：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-06-30T00:00:00","StockCode":"600090","StockTicker":"*ST济堂","Url":"http://static.cninfo.com.cn/finalpage/2020-06-30/1207969780.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=ev/a8T8fDirg09mkV2GYhkWubWx9ZAxfE0Tg84yxbZf7apzzNAQ6og==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600090/2020-06-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600090\t公司简称：同济堂<br />新疆同济堂健康产业股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报..."},"Highlight":{"Content":["@4@29@报告期，在《“<em>健康中国2030</em>”规划纲要》、《“十三五”期间深化医药卫生体制改革规划》、《国务院办公厅关于进一步改革完善药品生产流通使用政策的若干意见》和《印发关于在公立医疗机构药品采购中推行“两票制”的实施意见（试行）的通知》等纲领性政策文件的指导下，公立医院改革深入推进，“三医联动”、带量采购、阳光招标、两票制全面落地等一系列医改政策的持续推进，分级诊疗演进出新模式、新路径，医保控费升级、目录更新、支付制度改革试点等，推动医药终端市场向更多元、更合理的方向发展。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"52432752","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"RzNvnu3PQabzgbsAb0x9Gg==","EncryptionKey":"UnpOdm51M1BRYWJ6Z2JzQWIweDlHZz09","Title":"千山退：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-06-30T00:00:00","StockCode":"300216","StockTicker":"千山退","Url":"http://static.cninfo.com.cn/finalpage/2020-06-30/1207967627.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=/7Dor8zHPmffqLSbK5NAyyftzR2f3h2fKK5VKfSzR1CY/J13IYUIeg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300216/2020-06-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"湖南千山制药机械股份有限公司 \u0000<br />201\u00009 \u0000 年度报告 \u0000<br />&emsp;&emsp;股票代码： \u0000 300216 \u0000<br />&emsp;&emsp;股票简称：千山药机 \u0000<br />&emsp;&emsp;披露时间：二○\u0000二○\u0000年\u0000六\u0000月 \u0000<br />"},"Highlight":{"Content":["大。近年来，党中央国务院高度重视医药卫生事业发展，“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"52341832","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"xAQ7H3cHQceYjGbS7vrr6A==","EncryptionKey":"eEFRN0gzY0hRY2VZakdiUzd2cnI2QT09","Title":"*ST辅仁：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-06-24T00:00:00","StockCode":"600781","StockTicker":"*ST辅仁","Url":"http://static.cninfo.com.cn/finalpage/2020-06-24/1207956929.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=7GmPwhvfmNrQz6wWNtoehaIMalIxkJGH0bicVnHRiaKn1MMEmxKQlQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600781/2020-06-24 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600781 \u0000 \u0000\t公司简称：\u0000 ST \u0000辅仁\u0000<br />辅仁药业集团制药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br /> \u0000<br />"},"Highlight":{"Content":["《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"52284224","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ae4Jat6gsI/aMMOY+eoZag==","EncryptionKey":"YWU0SmF0NmdzSS9hTU1PWStlb1phZz09","Title":"太安堂：2019年年度报告（更新后）","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-06-20T00:00:00","StockCode":"002433","StockTicker":"太安堂","Url":"http://static.cninfo.com.cn/finalpage/2020-06-20/1207944774.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=4kSjGIhAIcMMK2PhHc0bG7O3DGZTYoHPbp7R5f/6CcIpRvBWJLf6Yg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002433/2020-06-20 2019年年度报告（更新后）.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"广东太安堂药业股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />广东太安堂药业股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>","<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"52177462","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"xBT4OkLyc1YMk1/+KM1Qvw==","EncryptionKey":"eEJUNE9rTHljMVlNazEvK0tNMVF2dz09","Title":"大湖股份：2019年年度报告（修订版）","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-06-12T00:00:00","StockCode":"600257","StockTicker":"大湖股份","Url":"http://static.cninfo.com.cn/finalpage/2020-06-12/1207919493.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"渔业","ParentIndustry":"农、林、牧、渔业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=qZ7fgdhMTvMIZNsKdTz7WSI58E4fqESDsCi5Xe32tps6cX2YAzV3AA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600257/2020-06-12 2019年年度报告（修订版）.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600257 \u0000 \u0000 公司简称：\u0000 大湖股份\u0000<br />&emsp;&emsp;大湖水殖股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000145\u0000<br />"},"Highlight":{"Content":["《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"52122187","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ggu03j7oaLZdo0lmL5uNNA==","EncryptionKey":"Z2d1MDNqN29hTFpkbzBsbUw1dU5OQT09","Title":"灵康药业：2019年年度报告（修订版）","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-06-08T00:00:00","StockCode":"603669","StockTicker":"灵康药业","Url":"http://static.cninfo.com.cn/finalpage/2020-06-08/1207904871.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=NYFh59BpcNLK5dbbzI0huomr9UaKFfeXf+nMWuhPJNpvmfvimz9NaA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603669/2020-06-08 2019年年度报告（修订版）.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603669 \u0000 \u0000 公司简称：\u0000 灵康药业\u0000<br />&emsp;&emsp;灵康药业集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000204\u0000<br />"},"Highlight":{"Content":["随着“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51993161","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"7AJkATaJ0rO14LmIDE0FMA==","EncryptionKey":"N0FKa0FUYUowck8xNExtSURFMEZNQT09","Title":"*ST中珠：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-05-30T00:00:00","StockCode":"600568","StockTicker":"*ST中珠","Url":"http://static.cninfo.com.cn/finalpage/2020-05-30/1207875407.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=6+MJ2jNpLrnqQLEUhB6vP9LK5bfhC35PV4+hLkiqWYAnnrS1U/vqXg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600568/2020-05-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600568 \u0000 公司简称：中珠医疗\u0000<br />中珠医疗控股股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000242\u0000<br />"},"Highlight":{"Content":["了明显提升，而完善健康保障体系也是“<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51993172","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"6KONr67aT9zz76sXU2uPag==","EncryptionKey":"NktPTnI2N2FUOXp6NzZzWFUydVBhZz09","Title":"*ST中珠：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-05-30T00:00:00","StockCode":"600568","StockTicker":"*ST中珠","Url":"http://static.cninfo.com.cn/finalpage/2020-05-30/1207875394.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=4BHceHsTzQukuY5fY7HpB4dfOuH1CC5bKrRmJgPhsDXUf7JM3mcLKg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600568/2020-05-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600568\t公司简称：中珠医疗<br />中珠医疗控股股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内..."},"Highlight":{"Content":["@10@90@加大了对医疗卫生服务行业的扶持力度。国家政策支持、居民消费能力和健康意识提升、人口老龄化加速以及医疗服务消费结构升级等因素都促进了国内健康服务需求的快速增长，医疗与健康产业市场总量持续扩大。过去的一年里，基本医疗保障制度不断完善，覆盖的广度和深度都得到了明显提升，而完善健康保障体系也是“<em>健康中国2030</em>”中的重点内容。医疗服务行业是医疗健康产业的重要分支，老龄人口对医疗服务消费较其他组别有更明显的推动作用。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51897565","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"67uhZHqh0c2E/eFn1wUMkA==","EncryptionKey":"Njd1aFpIcWgwYzJFL2VGbjF3VU1rQT09","Title":"通策医疗：2019年年度报告（修订版）","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-05-23T00:00:00","StockCode":"600763","StockTicker":"通策医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-05-23/1207851122.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=63nmpB81mpdnuOrzWjP8izT04mxdEXxt9z0F91/CdIRg19JfF/BHnA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600763/2020-05-23 2019年年度报告（修订版）.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600763 \u0000 \u0000 公司简称：\u0000 通策医疗\u0000<br />&emsp;&emsp;通策医疗股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1\u0000/\u0000198\u0000<br />"},"Highlight":{"Content":["）》，提出贯彻落实《<em>健康中国</em>","<em>2030</em>","亿人。国务院发布《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51850548","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"aq6mS9qmsMw1BOdtdEumXA==","EncryptionKey":"YXE2bVM5cW1zTXcxQk9kdGRFdW1YQT09","Title":"香雪制药：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-05-20T00:00:00","StockCode":"300147","StockTicker":"香雪制药","Url":"http://static.cninfo.com.cn/finalpage/2020-05-20/1207831728.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=2oqiqQ4i/fJ7PGsn+JgfUYK6LCTQuENFmryTdWoFcKP8DEDeg1E8ZA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300147/2020-05-20 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300147 \t证券简称：香雪制药\t公告编号：2020-046<br />&emsp;&emsp;广州市香雪制药股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />&emsp;&emsp;本公司董事会..."},"Highlight":{"Content":["@6@63@设施标准、管理规范、特色鲜明的道地药材生产基地，培育一批创新力强、规模大的中药企业集团，创响一批有信誉、有影响的中药知名品牌，努力提升中药材质量效益和产业竞争力”；《中医药发展“十三五”规划》：“促进中药材种植养殖业绿色发展”；《中医药健康服务发展规划（2015-2020年）》明确提出：“大力实施中药材生产质量管理规范（GAP），扩大中药材种植和贸易”；《国务院办公厅关于促进医药产业健康发展的意见》：“促进中药资源可持续发展，加强对中药资源的保护、研究开发和合理利用”；《“<em>健康中国2030</em>”规划纲要》：“加强中药新药创新能力建设，大力发展优质中药，健全质量标准体系，提升质量控制技术，实施绿色和智能改造升级”。国际、国内对中医药的发展日益重视，中医药的国际化发展获得了更多的空间。","@6@64@&emsp;&emsp;随着中国人口老龄化不断加深和《“<em>健康中国2030</em>”规划纲要》的制定，预计到2020年，中国健康产业产值将达到8万亿，到2030年达到16万亿元，成为国民经济的支柱性产业。根据国务院新闻办发布的《中国的中医药》白皮书，至2020年，我国中医药大健康产业将突破3万亿，年均复合增长率将保持在20%。随着居民消费水平的提高，更多人民群众开始关注养生保健，各类中成药需求在不断增大，未来我国中医药行业具有强大的潜在发展空间。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51850521","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"kTNJL7ed4Szdz2Hv9/hKuA==","EncryptionKey":"a1ROSkw3ZWQ0U3pkejJIdjkvaEt1QT09","Title":"香雪制药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-05-20T00:00:00","StockCode":"300147","StockTicker":"香雪制药","Url":"http://static.cninfo.com.cn/finalpage/2020-05-20/1207831755.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=ZTcyRY0QcRT58m2vBXNw/X7jIgzdopLV2ycAKvnjANXcmJe4upaGVQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300147/2020-05-20 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;广州市香雪制药股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />广州市香雪制药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;20\u000020\u0000-\u00000\u000045\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 05 \u0000 月 \u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>","<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51671935","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"4chUfalj10W/7VO1k53/9g==","EncryptionKey":"NGNoVWZhbGoxMFcvN1ZPMWs1My85Zz09","Title":"延安必康：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-05-07T00:00:00","StockCode":"002411","StockTicker":"延安必康","Url":"http://static.cninfo.com.cn/finalpage/2020-05-07/1207709286.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=hX9mGlU4beffHGlzcdO3rUlyfF9DuEojjl0gjRKIMBQy5Ro+Vc6TIA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002411/2020-05-07 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;延安必康制药股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />延安必康制药股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 05 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-92774","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"0Csp137CwmzfshTVN2TZ2A==","EncryptionKey":"MENzcDEzN0N3bXpmc2hUVk4yVFoyQT09","Title":"嘉必优：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"688089","StockTicker":"嘉必优","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207692724.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=tXLsuRs8ZM7i8Oh/JvHpvwx5hnmbq804wQPS/iIbMpTUX9uL+e9cTw==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688089/2020-04-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688089\t公司简称：嘉必优<br />嘉必优生物技术（武汉）股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 重大风险提示<br />"},"Highlight":{"Content":["@5@47@健康与长寿是人类永恒的追求，随着物质生活的日益丰富，人们对于健康的关注度越来越高，营养、健康等领域已成为人们关注的重点。根据中共中央、国务院颁布的《“<em>健康中国2030</em>”规划纲要》，到2020年，国内的健康服务业规模将超过8万亿元，到2030年，这一数字则将超过16万亿元。预计我国营养素及健康解决方案的需求将持续增长。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-92763","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"iFQsUntmnPI7k24J4HgXaw==","EncryptionKey":"aUZRc1VudG1uUEk3azI0SjRIZ1hhdz09","Title":"嘉必优：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"688089","StockTicker":"嘉必优","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207692735.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=/FUHVx4jkshZnpN3by3uV1hi/hbHRKpEzEZ0DYIYdI05CtxNrrXqvg==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688089/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688089\t公司简称：嘉必优<br />嘉必优生物技术（武汉）股份有限公司<br />2019 年年度报告<br />&emsp;&emsp;重要提示<br />一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整，<br />"},"Highlight":{"Content":["@12@111@&emsp;&emsp;健康与长寿是人类永恒的追求，随着物质生活的日益丰富，人们对于健康的关注度越来越高，营养、健康等领域已成为人们关注的重点。根据中共中央、国务院颁布的《“<em>健康中国2030</em>”规划纲要》，到2020年，国内的健康服务业规模将超过8万亿元，到2030年，这一数字则将超过16万亿元。预计我国营养素及健康解决方案的需求将持续增长。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51471714","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"iqU9LPsxPpWTegdkSaVvGg==","EncryptionKey":"aXFVOUxQc3hQcFdUZWdka1NhVnZHZz09","Title":"方盛制药：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"603998","StockTicker":"方盛制药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207694874.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=md8Sr9UjIgi0Ie2/+adMD7pqxxdYYv3gDE6fY4trnefqcDKGwRASGA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603998/2020-04-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：603998\t公司简称：方盛制药<br />湖南方盛制药股份股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报..."},"Highlight":{"Content":["@5@37@&emsp;&emsp;公司的产品多为中成药与化学药品制剂。化学药品制剂是所有药品中数量、品种最多的类别，也是居民日常生活中使用最广泛的类别，居我国医药工业的龙头地位。我国医药制造业规模以上工业企业主营业务收入2012年-2018年复合增长率远高于同期GDP增长率。2020年1月，全球爆发“新冠”疫情之后，对医疗的需求持续增加，民众健康意识大幅提高，叠加“<em>健康中国2030</em>”战略的实施、人口老龄化、社会医疗卫生支出和研发投入等因素，预计全球医药市场尤其是我国医药市场将继续保持着稳定增长，市场前景依旧十分广阔，与此同时，行业内的竞争更加激励。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51471713","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"1hCHUQk/jsbb1+A3ZfjRnQ==","EncryptionKey":"MWhDSFVRay9qc2JiMStBM1pmalJuUT09","Title":"方盛制药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"603998","StockTicker":"方盛制药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207694875.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=x5jHAjSy5isQ3TA3Yli1kjCnG8doXqsj7CYpl5gc2XW3QU3xiZbcLg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603998/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：\u0000 603998 \u0000 \u0000 公司简称：\u0000 方盛制药\u0000<br />&emsp;&emsp;湖南方盛制药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;20\u000020 \u0000 年 \u0000 4 \u0000 月 \u0000 30 \u0000 日 \u0000<br />&emsp;&emsp;方盛制药·\u0000 2019 \u0000 年年度报告 \u0000<br />"},"Highlight":{"Content":["民众健康意识大幅提高，叠加“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51471368","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"qp3GksHFqjubZLduf7ARvg==","EncryptionKey":"cXAzR2tzSEZxanViWkxkdWY3QVJ2Zz09","Title":"珍宝岛：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"603567","StockTicker":"珍宝岛","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207695160.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=OBJwpjGSicQUjznpmui7L0JrD2sXOCJ7jY8teUKz4dVbbS59XwOnwg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603567/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603567 \u0000 \u0000\t公司简称：\u0000 珍宝岛\u0000<br />黑龙江珍宝岛药业股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000197\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","”<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51471371","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"milYfYuzJWsKIxk6OqL8sg==","EncryptionKey":"bWlsWWZZdXpKV3NLSXhrNk9xTDhzZz09","Title":"珍宝岛：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"603567","StockTicker":"珍宝岛","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207695157.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=C+XefCd7uFhsF6SudfinX10YHQyW9AehSNUuqU3aeg7n9025x1roKw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603567/2020-04-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：603567\t公司简称：珍宝岛<br />黑龙江珍宝岛药业股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告..."},"Highlight":{"Content":["@5@58@&emsp;&emsp;10月20日，国务院办公厅印发《中共中央国务院关于促进中医药传承创新发展的意见》。内容主要包括：健全中医药服务体系、发挥中医药在维护和促进人民健康中的独特作用、大力推动中药质量提升和产业高质量发展、加强中医药人才队伍建设、促进中医药传承与开放创新发展、改革完善中医药管理体制机制六大部分。全面系统的高度关注使得中医药传承创新发展刻不容缓。《“<em>健康中国”2030</em>规划》《国家医保目录2019版》品种中西药占比各半、《关于在医疗联合体建设中切实加强中医药的通知》等政策的颁布都为中医药发展注入了新时期的强心剂。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51472705","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"h0pEBsnX4y9FDPXvvPd/oA==","EncryptionKey":"aDBwRUJzblg0eTlGRFBYdnZQZC9vQT09","Title":"广誉远：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"600771","StockTicker":"广誉远","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207694060.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=+e/sCXMEmVJt6pkeNuxWTFZUfK5hQV5edgF4xIyMpM1Gfmu1F+qAkQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600771/2020-04-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600771\t公司简称：广誉远<br />广誉远中药股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />&emsp;&emsp;二○二○年四月三十日<br />一 重要提示<br />"},"Highlight":{"Content":["@6@48@&emsp;&emsp;2、顶层设计推动中医药传承创新，行业有望迎来新局面中医药文化是中华文明的重要组成部分，经过几千年的传承，已经拥有了比较成熟的理论体系和实践经验，对中华民族的传承与发展作出了不可磨灭的贡献，特别是在 2020 年初爆发的新型冠状病毒肺炎疫情（以下简称：新冠疫情）防治中发挥了重要的作用，进一步提升了其在广大人民群众心目中的影响和地位，再次证明了中医药行业是国家医疗卫生保健体系中不可或缺的一分子。近年来中医药行业利好政策频频出台，继《中医药法》、《“<em>健康中国2030</em>”规划纲要》陆续颁布实施后，2019 年 10 月20 日发布的《关于促进中医药传承创新发展的意见》更是将推动中医药行业的传承与创新上升到了国家战略的高度。随着国家在顶层设计层面正式明确中医药行业在国家医疗卫生保健体系和国民经济中的定位与发展战略，加之中医药在一次又一次的临床实践中成功为国家与人民“保驾护航”，中医药行业有望迎来一个全面发展的新局面。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51472704","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"WlM9aL3+pNj1hp4nWtbtLg==","EncryptionKey":"V2xNOWFMMytwTmoxaHA0bld0YnRMZz09","Title":"广誉远：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"600771","StockTicker":"广誉远","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207694061.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=a0q0u/44E/s6jeaj12rgEKnjHN+yyH7R/BlOC2kgahK5eOcBSfr4WQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600771/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：\u0000 600771 \u0000 \u0000 公司简称：\u0000 广誉远\u0000<br />&emsp;&emsp;广誉远中药股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;二○二○年\u0000四\u0000月\u0000三十\u0000日\u0000<br />&emsp;&emsp;广誉远中药股份有限公司 \u0000 2019 \u0000年年度报\u0000告 \u0000<br />"},"Highlight":{"Content":["@15@149@&emsp;&emsp;近年来中医药行业利好政策频频出台，继《中医药法》、《“<em>健康中国</em>","<em>2030</em>”","@36@363@&emsp;&emsp;《“<em>健康中国</em>","<em>2030</em>","@56@610@&emsp;&emsp;近年来，国家高度重视中医药传承创新发展，继《中医药法》《<em>健康中国</em>“","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=a0q0u/44E/s6jeaj12rgEKnjHN+yyH7R/BlOC2kgahK5eOcBSfr4WQ==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51476227","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"8lYR3IFLAvcCGzL6LcX19w==","EncryptionKey":"OGxZUjNJRkxBdmNDR3pMNkxjWDE5dz09","Title":"华海药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"600521","StockTicker":"华海药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207690479.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=FtmVBQStLJSiqo6UW5BcKfBsiGEdENgdCIFLgD4luWHuoT8WR/KzNA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600521/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600521 \u0000 \u0000 公司简称：\u0000 华海药业\u0000<br />&emsp;&emsp;浙江华海药业股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000199\u0000<br />"},"Highlight":{"Content":["国务院发布的《“<em>健康中国</em>","<em>2030</em>","管理、再到治疗的全产业发展规划，是即《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51476682","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"m0C41/TgYmmXz0MCH5bA1g==","EncryptionKey":"bTBDNDEvVGdZbW1YejBNQ0g1YkExZz09","Title":"青海春天：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"600381","StockTicker":"青海春天","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207690049.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=tgTUjSCq9NVVEVX+GnyJPi7GTmWoxSGpI7K3YLHZAvc2m5oi1/5S9w==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600381/2020-04-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600381\t公司简称：青海春天<br />青海春天药用资源科技股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年..."},"Highlight":{"Content":["@3@27@&emsp;&emsp;因行业政策尚未明朗，以及近年来市场对冬虫夏草安全性和功效的误读，整个冬虫夏草行业，尤其是冬虫夏草高效利用和深加工行业，处于较为低迷的情况。2016 年 10 月，中央和国务院发布了《“<em>健康中国2030</em>”规划纲要》，是建国以来首次在国家层面提出的健康领域中长期战略规划，是2030年前推进健康中国建设的行动纲领，是保障人民健康的重大举措。2019年10月国务院发布的《关于促进中医药传承创新发展的意见》，提出了通过“传承精华，守正创新”大力促进我国中医药传承创新发展、推动中医药事业和中医药产业的高质量发展的意见和要求，国家中医药管理局也发布了《关于印发<中共中央国务院关于促进中医药传承创新发展的意见>重点任务分工方案的通知》。以上政策的发布，更加坚定了公司在冬虫夏草产业方面坚守的决心，公司将继续保持对冬虫夏草的基础研究和新产品研发储备工作，等待行业相关政策的出台。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51476674","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"LeRRx0En07M8GrQ+Su2slg==","EncryptionKey":"TGVSUngwRW4wN004R3JRK1N1MnNsZz09","Title":"青海春天：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"600381","StockTicker":"青海春天","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207690058.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=YcYxMu5cn6OrqOKVtTf+tKlFuv4TRuHHjlBr5+PZIfGaD/30dDqBtg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600381/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600381 \u0000 \u0000 公司简称：\u0000 青海春天\u0000<br />青海春天药用资源科技股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000191\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","@26@396@&emsp;&emsp;《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51477314","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"sy57M9nS4pFO2x4ZNUFGMA==","EncryptionKey":"c3k1N005blM0cEZPMng0Wk5VRkdNQT09","Title":"大湖股份：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"600257","StockTicker":"大湖股份","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207689493.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"渔业","ParentIndustry":"农、林、牧、渔业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Y0GeJqAZAyZzlXrKFbSXgE1b9p0JLeGD6Ib9POs3zaYS2sQLpPwPyA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600257/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600257 \u0000 \u0000 公司简称：\u0000 大湖股份\u0000<br />&emsp;&emsp;大湖水殖股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000145\u0000<br />"},"Highlight":{"Content":["《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51477315","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"jixoXCUHGkZLaAFR2VUWYQ==","EncryptionKey":"aml4b1hDVUhHa1pMYUFGUjJWVVdZUT09","Title":"大湖股份：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"600257","StockTicker":"大湖股份","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207689492.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"渔业","ParentIndustry":"农、林、牧、渔业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=tcyrjIT7AYhgIAHD6tqGQby8ci/NSYpo5yUkXRSEmcYixXktwvswKQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600257/2020-04-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600257\t公司简称：大湖股份<br />大湖水殖股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的..."},"Highlight":{"Content":["@3@25@&emsp;&emsp;2019年医疗保健人均支出1902元，增长率为12.9%。随着国家医药卫生体制改革和“<em>健康中国2030</em>”战略的不断推进，在消费升级、人口老龄化、社会消费水平提高等大背景下，包含医药保健产品、营养保健产品、休闲保健服务、医疗保健器械、康复理疗等多个与人类健康紧密相关的医药健康产业，将会迎来更大的发展机会。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51478442","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"XQ6YtfDi/zgU1366nlXQtw==","EncryptionKey":"WFE2WXRmRGkvemdVMTM2Nm5sWFF0dz09","Title":"ST金花：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"600080","StockTicker":"ST金花","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207688563.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=/Hb1q4JcRKhAs/+zJlcCfYmQbx4PXOM+L2uL3Ew44M73YPDcpLIyNw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600080/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600080 \u0000 \u0000 公司简称：\u0000 金花股份\u0000<br />金花企业（集团）股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000166\u0000<br />"},"Highlight":{"Content":["资源。近年来，国家出台了一系列政策大力发展中医药产业。《“<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51486118","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"hwsrG4ytTCH0fpitYIpzbg==","EncryptionKey":"aHdzckc0eXRUQ0gwZnBpdFlJcHpiZz09","Title":"贵州百灵：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"002424","StockTicker":"贵州百灵","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207686269.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=2uPji3InxtYkKxwvihBQsU4Y/5ifuWKffQ8m+AK34VS9jUyt50V6dg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002424/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;贵州百灵企业集团制药股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />贵州百灵企业集团制药股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000034\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=2uPji3InxtYkKxwvihBQsU4Y/5ifuWKffQ8m+AK34VS9jUyt50V6dg==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51485985","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"J/eFZhua2h+UXvjjDoZRdw==","EncryptionKey":"Si9lRlpodWEyaCtVWHZqakRvWlJkdz09","Title":"美年健康：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"002044","StockTicker":"美年健康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207686656.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=rqkT4HrV1SasCa+7h4Ac36fxchuBuwU4KHfjhdVPjWXbSt41hsbOCQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002044/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;美年大健康产业控股股份有限公司 \u0000 2019 \u0000年度报告全文\u0000<br />美年大健康产业控股股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年度\u0000报告 \u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51485966","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"BB74KDd0nUkJ0eXburt9fA==","EncryptionKey":"QkI3NEtEZDBuVWtKMGVYYnVydDlmQT09","Title":"美年健康：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"002044","StockTicker":"美年健康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207686654.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=OOuK8+D/OgfNldqM8jKEAYfWtaWhoinSFcldhiGCHQ5sI7oy7aD05Q==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002044/2020-04-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：002044 \t证券简称：美年健康\t公告编号：2020-032<br />&emsp;&emsp;美年大健康产业控股股份有限公司<br />&emsp;&emsp;2019 年度报告摘要<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />一、重要提示<br />"},"Highlight":{"Content":["@9@97@&emsp;&emsp;美年健康始终坚守初心和医疗的本质，从预防入手，把握数据智能技术与健康消费升级的契机，不断强化品质内涵和学科学术建设，打造互联互通、共享开放、携手并进的产业发展环境，是未来美年健康的发展方向，也是深入贯彻落实“<em>健康中国2030</em>”规划纲要的重要举措。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51461695","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"KqTUzzwjybNJ0tK/aCorrw==","EncryptionKey":"S3FUVXp6d2p5Yk5KMHRLL2FDb3Jydz09","Title":"九芝堂：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"000989","StockTicker":"九芝堂","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207679259.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=tCtHywivHT2mUNITbGBxvnYgK9NwU+WMKis/o6lzLAohFg6Z2JHKpw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000989/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;九芝堂股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />九芝堂股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000022\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["一种绿色的健康理念。《<em>健康中国</em>","<em>2030</em>","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51468693","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"oMmgq6HdlSAIkRV2FoVSKg==","EncryptionKey":"b01tZ3E2SGRsU0FJa1JWMkZvVlNLZz09","Title":"中关村：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"000931","StockTicker":"中关村","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207684905.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=1Vox2vTJamlUG8yA53MVC9J2REBS0rs5LYOXT51U4NATsC9WldZOlA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000931/2020-04-30 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：000931\t证券简称：中关村\t公告编号：2020-040<br />&emsp;&emsp;北京中关村科技发展(控股)股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />"},"Highlight":{"Content":["@3@39@&emsp;&emsp;当前，外部国际经济走势下行趋势明显，但我国经济韧性强，国民经济总体依旧保持在合理运行区间，长期向好的经济基本面没有改变。纵观医药行业，在“<em>健康中国2030</em>”战略背景下，政府对医疗卫生方面的投入逐步加大。受益于医保覆盖面增长、人均医疗消费增长、社会人口老龄化程度日益加剧以及居民健康意识不断提升等因素，我国医药市场总量进一步扩容。报告期内，新修订的《药品管理法》在2019年12月1日正式执行，本次修订的一个重要内容是取消执行多年的GMP认证和GSP认证，其根本意义在于取消之前药品注册与生产许可的捆绑模式，全面推行新的药品上市许可持有人制度。随着制度的实施，将在药品研发、生产、流通及医用等环节建立全流程监管网，对各环节施加更高的责任约束。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51468699","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"WPzu+wR7IOQXJvUP1SB4MA==","EncryptionKey":"V1B6dSt3UjdJT1FYSnZVUDFTQjRNQT09","Title":"中关村：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"000931","StockTicker":"中关村","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207684909.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=RUq0qMh61zyO6qoWcpTveGiAyyRxRfZiMlPmrs96W9ec1nCZ038Kpg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000931/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;北京中关村科技发展\u0000(\u0000控股\u0000)\u0000股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />北京中关村科技发展（控股）股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000039\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51463592","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"iwi72KjF5iuJK7fyfrj+hQ==","EncryptionKey":"aXdpNzJLakY1aXVKSzdmeWZyaitoUT09","Title":"西王食品：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-30T00:00:00","StockCode":"000639","StockTicker":"西王食品","Url":"http://static.cninfo.com.cn/finalpage/2020-04-30/1207680236.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"农副食品加工业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=sD5AaYIOc7QQB3758bKE4N3HkZGnW1jG4O9def8awL0e8reLUwKgpA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000639/2020-04-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"西王食品股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;西王食品股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月 \u0000<br />1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51428615","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"c6tFAr8u3r5Ky9jxuHpnHA==","EncryptionKey":"YzZ0RkFyOHUzcjVLeTlqeHVIcG5IQT09","Title":"蔚蓝生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"603739","StockTicker":"蔚蓝生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207671055.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=sOHgyH8J0Y7i5PBROFTThWSsMP/TBQgWQUH7HMlX2GM7G6xK6nsFWw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603739/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603739 \u0000 \u0000 公司简称：\u0000 蔚蓝生物\u0000<br />&emsp;&emsp;青岛蔚蓝生物股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1\u0000/\u0000187\u0000<br />"},"Highlight":{"Content":["我国的《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51424951","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"+9S61YM5twyIT6miKZ3YZQ==","EncryptionKey":"KzlTNjFZTTV0d3lJVDZtaUtaM1laUT09","Title":"中源协和：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"600645","StockTicker":"中源协和","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207668270.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"研究和试验发展","ParentIndustry":"科学研究和技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=StgZr0lPb6QVUvNc9DYHp2es2IN6cO8/WNSPmFID+yi1Entp794zWA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600645/2020-04-29 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600645\t公司简称：中源协和<br />中源协和细胞基因工程股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年..."},"Highlight":{"Content":["@5@50@&emsp;&emsp;中国政府高度重视干细胞科技的发展，干细胞被纳入《“十三五”国家战略性新兴产业发展规划》及《“<em>健康中国2030</em>”规划纲要》中，计划3年20亿元财政拨款支持干细胞及转化研究的原创性突破和推动转化，以提高我国再生医学领域水平。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51424940","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"FZzEPy+UsfOuMbK4HgxL1g==","EncryptionKey":"Rlp6RVB5K1VzZk91TWJLNEhneEwxZz09","Title":"中源协和：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"600645","StockTicker":"中源协和","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207668281.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"研究和试验发展","ParentIndustry":"科学研究和技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=D7cAc3zkjWGgJoKBSjjo+Jqkwa7w5UWIhRkc94+qDtDIDL6lJ4Ot8A==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600645/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600645 \u0000 \u0000 公司简称：\u0000 中源协和\u0000<br />中源协和细胞基因工程股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000212\u0000<br />"},"Highlight":{"Content":["规划》及《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51431793","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Va24Nygeat2F80yR8GwZRg==","EncryptionKey":"VmEyNE55Z2VhdDJGODB5UjhHd1pSZz09","Title":"*ST交昂：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"600530","StockTicker":"*ST交昂","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207668077.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=/0bJ+O5mFOQWxia3r/WUn8NrWcAO3420gNnXMgRM6ocHaD3PQ2ORDw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600530/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600530 \u0000 \u0000 公司简称：\u0000 交大昂立\u0000<br />上海交大昂立股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;二〇二〇年四月\u0000<br />"},"Highlight":{"Content":["@22@372@&emsp;&emsp;《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51417399","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"7hylXmuw5n3BPX00xVKGiw==","EncryptionKey":"N2h5bFhtdXc1bjNCUFgwMHhWS0dpdz09","Title":"羚锐制药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"600285","StockTicker":"羚锐制药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207654491.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=4bJ2TbEshaoo7vLuZfBeGTfXL9AGxh6fkBvYZltS39WFq0un38mogQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600285/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600285 \u0000 \u0000\t公司简称：\u0000 羚锐制药\u0000<br />&emsp;&emsp;河南羚锐制药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000215\u0000<br />"},"Highlight":{"Content":["@24@282@&emsp;&emsp;近年来，国家高度重视中医药行业的发展，《中华人民共和国中医药法》、《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51423587","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"3eSLr44u/pGoIOa0X41WEw==","EncryptionKey":"M2VTTHI0NHUvcEdvSU9hMFg0MVdFdz09","Title":"恒锋信息：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"300605","StockTicker":"恒锋信息","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207660191.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=/WUAQBEVR3kebhYar4PcmKz8wjA5V3RmPm5ubOoYvr3sF4Mtk7RIDA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300605/2020-04-29 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300605 \t证券简称：恒锋信息\t公告编号：2020-031<br />&emsp;&emsp;恒锋信息科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@2@39@&emsp;&emsp;近年来我国医疗健康服务供需不平衡的问题凸显。为合理分配优质医疗资源，调节医疗服务供需平衡，政府推出多项医疗改革政策，鼓励利用互联网、大数据、云计算等多领域技术与医疗健康领域跨界融合，发展远程医疗、互联网健康管理平台等智慧健康服务。2016年10月，国务院发布《“<em>健康中国2030</em>”规划纲要》，首次将有关健康医疗产业的纲要提到国家战略层面，明确了“互联网+医疗”的态度。2018年4月，国务院办公厅发布《关于促进“互联网+医疗健康”发展的意见》，提出健全涵盖医疗、医药、医保“三医联动”的“互联网+医疗健康”服务体系，完善“互联网+医疗健康”的支撑体系。2018年8月，国家卫健委发布《关于进一步推进以电子病历为核心的医疗机构信息化建设工作的通知》，明确“实现诊疗服务环节全覆盖”、“发挥临床诊疗决策支持功能”、“系统整合和互联互通”等三大建设内容。2019年3月，国家卫健委发布《医院智慧服务分级评估标准体系（试行）》，提出医院应针对患者的医疗服务需要，应用信息技术改善患者就医体验，提升医疗服务智慧化水平。2020年3月，国务院发布《关于深化医疗保障制度改革的意见》，多次提到互联网医疗，包括医保的对接、跨区域基金预算试点。2020年4月14日，国家发改委、中央网信办联合印发《关于推进“上云用数赋智”行动培育新经济发展实施方案》，提出已国家数字经济创新发展实验区为载体，在卫生健康领域探索推进互联网医疗医保首诊制和预约分诊制，开展互联网医疗的医保结算、支付标准、药品网售、分级诊疗、远程会诊、多点执业、家庭医生、线上生态圈接诊等改革试点、实践探索和应用推广。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51449602","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"yOCcCKcqhoAK9PLQnHUt9w==","EncryptionKey":"eU9DY0NLY3Fob0FLOVBMUW5IVXQ5dz09","Title":"易联众：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"300096","StockTicker":"易联众","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207665524.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Y8nzx+efv6JSVpPjnPyOMMjqt296vrp2+XV9oT5eQxu5Jla3nSN3qg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300096/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;易联众信息技术股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />易联众信息技术股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51441518","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ATpzc4M2xAD/YoadzYvgYw==","EncryptionKey":"QVRwemM0TTJ4QUQvWW9hZHpZdmdZdz09","Title":"瑞康医药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"002589","StockTicker":"瑞康医药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207666441.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Z19TXlF9BYtgruFv+o3w7xqa+7y3kPD9MxoV8XhhJj6aeUz6KTmL4A==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002589/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"瑞康医药集团股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />1\u0000<br />瑞康医药集团股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />"},"Highlight":{"Content":["@11@100@&emsp;&emsp;为落实<em>健康中国</em>","<em>2030</em>","@11@104@&emsp;&emsp;为全面落实<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51441516","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"dn1Q2BJEKhA07Gv4sYt7hQ==","EncryptionKey":"ZG4xUTJCSkVLaEEwN0d2NHNZdDdoUT09","Title":"瑞康医药：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"002589","StockTicker":"瑞康医药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207666425.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=i03rUgQVFsETKYLGluz5oydg+qwOug+uubN2akR+wtor/NznyvqYyA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002589/2020-04-29 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：002589\t证券简称：瑞康医药\t公告编号：2020-037<br />&emsp;&emsp;瑞康医药集团股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@2@35@&emsp;&emsp;为落实<em>健康中国2030</em>战略规划，落实人人享有公平可及基本医疗服务的总目标，依据保基本、强基层、建机制的总体理念；同时国家引导健康产业发展力度将进一步加大，为此国家相关部门将围绕医疗、医保、医药三医联动继续出台系统设计方案和改革举措，这将对医药行业未来发展趋势产生重大影响，归纳如下：","@3@39@为全面落实<em>健康中国2030</em>国家战略，国家为确保医保的可持续和参保患者的可及性，通过药品国家谈判、带量采购不断扩面以及尝试高值耗材带量采购等举措大幅压缩产品准入价格；同时由于加大行业合规力度、压缩流通环节、穿透式财税检查等因素同时影响，药品、器械耗材、检验材料等市场增速明显放缓。短期看市场进入平稳增长区间，从长期看医保完成“腾笼换鸟”后，患者的保障水平将得以提高，医疗消费需求将进一步释放，市场必将进入新的快速成长周期。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51423298","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Bgz9fTYYOtw7zMK6qzEUAA==","EncryptionKey":"Qmd6OWZUWVlPdHc3ek1LNnF6RVVBQT09","Title":"沃华医药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"002107","StockTicker":"沃华医药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207659981.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=QObahGgJdm4VArdAYPEZhwuM98BPpzf2sGO7V+EHZEU5KWT1ezn8qQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002107/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;山东沃华医药科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />山东沃华医药科技股份有限公司\u0000<br />Shandong Wohua Pharmaceutical Co., \u0000 Ltd\u0000<br />&emsp;&emsp;二\u0000〇\u0000一九\u0000年年度报告\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51423290","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"OBt9Adv5qiEFPsDpOhxnfw==","EncryptionKey":"T0J0OUFkdjVxaUVGUHNEcE9oeG5mdz09","Title":"沃华医药：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"002107","StockTicker":"沃华医药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207659977.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=M9qqp5RnaUM2s6FORP5IExTKJBwnYiJfLFHL9IyUchm6Ggt9wyUMSQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002107/2020-04-29 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：002107\t证券简称：沃华医药\t公告编号：2020-025<br />&emsp;&emsp;山东沃华医药科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />非标准审计意见提示<br />"},"Highlight":{"Content":["@9@79@&emsp;&emsp;中医药作为我国独特的卫生资源、潜力巨大的经济资源、具有原创优势的科技资源、优秀的文化资源和重要的生态资源，凭借其在治疗慢病领域的独特优势，在经济社会发展中发挥着更加重要的作用。中医中药有几千年文化的传承，具备深厚的社会文化基础，受众人群广泛。国家对中医药发展一贯秉持扶持和促进的态度，2016年，中共中央、国务院印发了《“<em>健康中国2030</em>”规划纲要》，明确提出“坚持中西医并重，传承发展中医药事业”。2017年7月1日，《中华人民共和国中医药法》正式实施，为继承和弘扬中医药、促进中医药事业发展提供了保障。2019年10月25日，全国中医药大会在北京召开，提出中医药要传承精华、守正创新，吹响了新时代中医药传承创新发展的号角；10月26日，国务院发布了《中共中央国务院关于促进中医药传承创新发展的意见》，指出要健全中医药服务体系，发挥中医药在维护和促进人民健康中的独特作用，大力推动中药质量提升和产业高质量发展，加强中医药人才队伍建设，促进中医药传承与开放创新发展，改革完善中医药管理体制机制，切实把中医药这一祖先留下的宝贵财富继承好、发展好、利用好。中医药的振兴发展进入了一个前所未有的机遇期，随着人口老龄化进程加快，患有心脑血管、慢性呼吸系统、骨骼系统等疾病的人群持续攀升，中医药凭借慢性病领域具有的独特优势，将在慢病预防和康复阶段发挥重要作用，为促进人民健康发挥积极作用。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51427876","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"PmmX9jQxOboWQaPVdaHFgQ==","EncryptionKey":"UG1tWDlqUXhPYm9XUWFQVmRhSEZnUT09","Title":"科华生物：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"002022","StockTicker":"科华生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207662813.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=o7ok9DC94O50TNo+LY4mdJuBH8C47OCBusR7CvcHPxtWsENdzma32A==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002022/2020-04-29 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：002022 \t证券简称：科华生物\t公告编号：2020-020<br />&emsp;&emsp;上海科华生物工程股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />&emsp;&emsp;公司全体董..."},"Highlight":{"Content":["@2@25@&emsp;&emsp;公司以“关注生命，追求卓越”为企业宗旨，以人才为根本，以培养专业化、国际化团队为重心，充分发挥公司在行业中的深厚积淀和综合竞争优势，以资本市场为依托，坚持“内生增长+外延扩张”的发展战略，努力打造享誉中外的“科华生物”品牌，谋求百年基业。科华生物正努力为客户和投资者创造长期、持续的价值增长和业绩回报，在精准医学领域为落实“<em>健康中国2030</em>”国家战略贡献应有的力量。","@3@33@&emsp;&emsp;从2003年的“非典”到2020年的“新冠肺炎”，疾病的确诊都是以医学检验为金标准。如果能做到早诊断，就能响应《<em>健康中国2030</em>规划纲要》提出的早发现，早治疗，早防控。医学检验在传染病的防控和诊疗中乃至国家的生物安全中发挥着不可或缺的极其重要的作用，在健康产业中占据着重要的战略地位。体外诊断影响绝大多数医疗决策及精准用药，但其费用占整个临床治疗费用的比重较低，可以在保障国民健康的同时，节约国家在公共卫生领域的财政支出。由中共中央、国务院于2016年10月印发并实施的《“<em>健康中国2030</em>”规划纲要》提出将健康中国上升为国家战略，大力推进“以治病为中心”向“以人民健康为中心”的转变；要求落实预防为主，强化早诊断、早治疗、早康复，实现全民健康。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51427892","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"JMEkLaH8hjjXMRHjzwufRQ==","EncryptionKey":"Sk1Fa0xhSDhoampYTVJIanp3dWZSUT09","Title":"科华生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"002022","StockTicker":"科华生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207662800.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=AaSRbrfOKhynDmmMsQtmSWkCPNn8czmCg9RRuWDhLzdhjLVLKYPwPA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002022/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;上海科华生物工程股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />上海科华生物工程股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月 \u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["增长和业绩回报，在精准医学领域为落实“<em>健康中国</em>","<em>2030</em>","就能响应《<em>健康中国</em>","<em>2030</em>","月印发并实施的《“<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=AaSRbrfOKhynDmmMsQtmSWkCPNn8czmCg9RRuWDhLzdhjLVLKYPwPA==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51421213","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"SU/vE/dKBI+sTfK0cTe8xg==","EncryptionKey":"U1UvdkUvZEtCSStzVGZLMGNUZTh4Zz09","Title":"世荣兆业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"002016","StockTicker":"世荣兆业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207657626.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"房地产业","ParentIndustry":"房地产业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=8HGJCKEN8X7qWI7dx0teX6aeSISb6gN+YX/fh9r82i2NmRZ2izIGeA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002016/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;广东世荣兆业股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />广东世荣兆业股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51438335","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"vEbFFRMSCrYhNbhb0Ryjdg==","EncryptionKey":"dkViRkZSTVNDclloTmJoYjBSeWpkZz09","Title":"国际医学：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"000516","StockTicker":"国际医学","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207665263.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Zk+NT1A9o+dljWrSwJChIqmkzm7WE3RDk5HS1J4WQhgT/oaFUW0Sbg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000516/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"西安国际医学投资股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月 \u0000 29 \u0000 日\u0000<br />&emsp;&emsp;西安国际医学投资股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;第一节重要提示、目录和释义\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","家《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51438334","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"l+sOPJ62uuGje4wn6pnmCg==","EncryptionKey":"bCtzT1BKNjJ1dUdqZTR3bjZwbm1DZz09","Title":"国际医学：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"000516","StockTicker":"国际医学","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207665264.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=kfgHLab2jM6tdd62ksLiVxNPBmbGgIe5iQAcGUFPSL6zUULEIwmeoQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000516/2020-04-29 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：000516 \t证券简称：国际医学\t公告编号：2020-008<br />&emsp;&emsp;西安国际医学投资股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />公司全体董事亲自出席了审议本次年报的董事会会议<br />"},"Highlight":{"Content":["@3@35@&emsp;&emsp;中共中央、国务院印发《“<em>健康中国2030</em>”规划纲要》提出，到2020年，健康服务业总规模超8万亿，到2030年达16万亿。在众多利好政策的激励、推动下，我国医疗行业将迎来更加广阔的发展前景。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51438282","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"sdwaE2JnqeIFhNFwup4Fpw==","EncryptionKey":"c2R3YUUySm5xZUlGaE5Gd3VwNEZwdz09","Title":"中国宝安：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-29T00:00:00","StockCode":"000009","StockTicker":"中国宝安","Url":"http://static.cninfo.com.cn/finalpage/2020-04-29/1207665323.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"综合","ParentIndustry":"综合","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=o6/uTUopmQ3I/ybP6TS/wI7nOb0ljXDRePK0WiJJ3rGW0NhkTFXvCg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000009/2020-04-29 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;中国宝安集团股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;2019 \u0000 年年度\u0000报告 \u0000<br />&emsp;&emsp;20\u000020 \u0000 年 \u0000 0\u00004 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />&emsp;&emsp;中国宝安集团股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />"},"Highlight":{"Content":["背景下，随着人口老龄化进程不断加快，人们对健康的关注和医疗保健的需求日益提高。随着《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51392856","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"dYFy10PulZBdwQCUsxWnSw==","EncryptionKey":"ZFlGeTEwUHVsWkJkd1FDVXN4V25Tdz09","Title":"步长制药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"603858","StockTicker":"步长制药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207650451.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=7pxDboXFS7teg6FbBjQzMNtMzqd9yGyCYRprYtgKTqMr9gKz/KPBXg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603858/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"山东步长制药股份有限公司 \u0000 201\u00009 \u0000年年度报告 \u0000 \u0000<br />公司代码：\u0000 603858 \u0000 \u0000 公司简称：\u0000 步长制药\u0000<br />&emsp;&emsp;山东步长制药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000215\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51391903","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"MtmRQg500W0qC8suqZ+9JA==","EncryptionKey":"TXRtUlFnNTAwVzBxQzhzdXFaKzlKQT09","Title":"良品铺子：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"603719","StockTicker":"良品铺子","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207651397.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"零售业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=sCeQth+zXuYGHxAGtNmJBUPCHoFFCUCtB5yGNz1Ep9uQHAzocjxliQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603719/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603719 \u0000 \u0000\t公司简称：\u0000 良品铺子\u0000<br />&emsp;&emsp;良品铺子股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;二零二零年四月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=sCeQth+zXuYGHxAGtNmJBUPCHoFFCUCtB5yGNz1Ep9uQHAzocjxliQ==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51391911","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"doLA3wZSmss5NhlJV0APYw==","EncryptionKey":"ZG9MQTN3WlNtc3M1TmhsSlYwQVBZdz09","Title":"良品铺子：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"603719","StockTicker":"良品铺子","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207651389.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"零售业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=oojytRGasktANFi8YaQPUR24x0EICloR7zUkee3wJenPmUeCOJ7l8A==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603719/2020-04-28 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：603719\t公司简称：良品铺子<br />良品铺子股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的..."},"Highlight":{"Content":["@5@22@（三）公司所处行业的情况说明 1、公司所处的行业。公司主要从事休闲食品的研发、采购、销售和运营业务。根据中国证券监督管理委员会《上市公司行业分类指引》（中国证券监督管理委员会公告[2012]31 号），公司所属行业为零售业（分类代码：F52）。2、行业发展趋势分析。（1）食品类商品消费支出将持续增加，优质企业规模增长空间巨大。2019年，国务院办公厅发布的《关于加快发展流通促进商业消费的意见》（国办发〔2019〕42 号）提出，要推动流通创新发展，优化消费环境，促进商业繁荣，激发国内消费潜力。根据国家统计局于2020年1月17日公布的数据显示，按零售业态分，2019年限额以上零售业单位中的超市、百货店、专业店和专卖店零售额比上年分别增长 6.5%、1.4%、3.2%和 1.5%，全国网上零售额 106324 亿元，比上年增长 16.5%。其中，实物商品网上零售额 85239 亿元，比上年增长 19.5%。在实物商品网上零售额中，吃、穿和用类商品分别比上年增长 30.9%、15.4%和 19.8%。按消费类型分，商品零售中的粮油、食品类和饮料类商品的全年零售总额绝对量均比上年增长超过10%，合计达到16624亿元。逾万亿的市场容量为优质食品企业提供了巨大的规模上升空间。（2）“健康中国”战略引领休闲食品行业开启营养健康的品质升级。中共中央、国务院于2016年10月印发的《“<em>健康中国2030</em>”规划纲要》提出，要制定、实施国民营养计划，深入开展食物（农产品、食品）营养功能评价研究，全面普及膳食营养知识，发布适合不同人群特点的膳食指南，引导居民形成科学的膳食习惯，推进健康饮食文化建设；要建立健全居民营养监测制度，对重点区域、重点人群实施营养干预，重点解决微量营养素缺乏、部分人群油脂等高热能食物摄入过多等问题，逐步解决居民营养不足与过剩并存问题；要加强对学校、幼儿园、养老机构等营养健康工作的指导。《“<em>健康中国</em> <em>2030</em>”规划纲要》还提出，到2030年，居民营养知识素养明显提高，营养缺乏疾病发生率显著下降，全国人均每日食盐摄入量降低 20%，超重、肥胖人口增长速度明显放缓。积极促进健康与食品等产业融合，催","@6@23@生健康新产业、新业态、新模式。为贯彻落实《“<em>健康中国2030</em>”规划纲要》，国务院办公厅于2017年7月印发的《国民营养计划（2017—2030）》（国办发〔2017〕60号）提出，要以改革创新驱动营养型农业、食品加工业等行业转型升级，丰富营养健康产品供给，促进营养健康与产业发展融合；要充分发挥营养相关专业学术团体、行业协会等社会组织，以及企业、个人在实施国民营养计划中的重要作用，推动社会各方良性互动、有序参与、各尽其责，使人人享有健康福祉。为实施健康中国行动，国务院于2019年7月印发的《国务院关于实施健康中国行动的意见》（国发〔2019〕13号）强调，合理膳食是健康的基础，提出要针对一般人群、特定人群和家庭加强营养和膳食指导，鼓励全社会参与减盐、减油、减糖，研究完善盐、油、糖包装标准，修订预包装食品营养标签通则，推进食品营养标准体系建设。数年来，“健康中国”战略已经从顶层设计迈入落地实施的进程中，势必推动休闲食品行业向健康优质的方向升级。公司的“高端零食”战略紧密切合“健康中国”的战略理念，坚持以“高品质”为产品核心价值，致力于满足不同细分市场的消费人群在不同生理状态下对营养健康的个性化需求、在不同购买任务下对不同使用场景的多样化需求，提供相应的休闲食品解决方案，符合休闲食品行业向注重食品卫生安全、食品营养健康升级的趋势。（3）社交零售对消费方式和销售贡献的影响愈发重要。休闲食品具有很强的社交属性，它的功能已不仅仅满足于食用，而且已经成为现代社会许多生活场景中的陪伴物、必需品。许多消费者在社交中获得商品信息，并且转发自己的购物链接或者购物体验。因此，休闲食品与顾客的交互触点愈发重要。社交零售是借助社交软件工具，以人为中心，社交为纽带的商业模式，依靠大数据技术，在社交软件上以短视频、直播、软文等热门形式面向细分人群提供以内容为核心的精准营销手段。在社交零售模式下，企业真正地以人为出发点，从经营商品向经营顾客价值转型。公司均衡的全渠道布局为公司在社交零售方面做出有益探索提供了坚实的基础。公司不依赖电商平台站内流量，而是从“站外”引流至“站内”，依托真切、丰富的传播内容，灵活运用微信、微博、小红书、抖音、直播、明星互动、影视剧植入、广告、导购等各种举措对消费人群实施精准营销，培育新的业务增长点。（4）消费升级大势之下，满足细分需求成为升级的突破口和品牌差异化的必由之路。休闲食品的消费人群具有人群范围广、消费周期长的特征。这决定了消费人群对休闲食品的需求一定是细分的。根据消费人群对不同营养健康、不同购买任务、不同使用场景的细分需求制定产品结构、产品标准、销售渠道和交互体验，是休闲食品行业转型升级的一个方向。3、公司行业地位良品铺子是全国驰名品牌，2019年公司产品在全渠道各类终端（包括公司自营和非自营终端）的销售额达到 97.37 亿元，公司的全资控股子公司湖北良品铺子食品工业有限公司被农村农业部认定为第六批农业产业化国家重点龙头企业。公司研发的高端零食享誉国际，成为业内少有的荣获多项国际食品大奖的企业。公司还荣获了 2019 年彼得·德鲁克中国管理奖提名奖，成为国内零食行业首个获奖品牌，评选委员会认为，良品铺子是行业持续创新的数字化转型标杆，良品铺子把零食做到了品质化，把管理做到了活性化，把零售做到了数据化，追求品质第一，通过持续创新来激活组织和为顾客创造价值。公司在业内率先提出“高端零食”战略，将战略中心聚焦到细分消费需求、坚持并不断提高产品品质上，部署了“产品做实高端+传播做实高端+体验做实高端”三位一体的举措，要强化顾客对“良品铺子=高端零食、高端零食=良品铺子”的认知，要从同质化、价格战的传统竞争格局中抽身，顺应健康中国的社会发展大趋势和安全、营养、健康的行业转型路径，抢占高端零食市场，实现差异化发展。报告期内，公司的主营业务、经营模式及行业情况没有发生重大变化。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51392089","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"VEK7BpFzHn/o8XESsR1Dhw==","EncryptionKey":"VkVLN0JwRnpIbi9vOFhFU3NSMURodz09","Title":"卫信康：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"603676","StockTicker":"卫信康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207651264.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=D7ExwzySKI46ZdLGI/gJpngXyi2uLXD3vTa5L6eJFiec7UGdrJR7ZA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603676/2020-04-28 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：603676\t公司简称：卫信康<br />西藏卫信康医药股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />&emsp;&emsp;2020 年 04 月<br />一 重要提示<br />"},"Highlight":{"Content":["@4@38@&emsp;&emsp;医药行业是国家战略性新兴产业，2019 年，我国医药工业大力实施<em>健康中国</em> <em>2030</em> 战略，全面推进医药产业高质量发展，近年来，随着国内仿制药一致性评价、“4+7”带量采购、药品上市许可持有人制度等政策相继落地，医药市场的整体格局正在加速变化，企业未来竞争愈加激烈，仿制药降价将是全国性的趋势，国内药企向研发创新转型迫在眉睫。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51392088","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"8+MkJ5x3RwFAK3TBcnTTFQ==","EncryptionKey":"OCtNa0o1eDNSd0ZBSzNUQmNuVFRGUT09","Title":"卫信康：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"603676","StockTicker":"卫信康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207651265.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=jEtfCpwEKppFUgxVc9Qv1jNeU85+LDt1Zj3tCp789RMv/0rTn1mBwg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603676/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603676 \u0000 \u0000\t公司简称：\u0000 卫信康\u0000<br />&emsp;&emsp;西藏卫信康医药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["年，我国医药工业大力实施<em>健康中国</em>","<em>2030</em>","随着《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51392583","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"EgIPtK8uLEjKn/CZKgcpjA==","EncryptionKey":"RWdJUHRLOHVMRWpLbi9DWktnY3BqQT09","Title":"大参林：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"603233","StockTicker":"大参林","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207650898.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"零售业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=SR0NA+7WYGNVN1dfwRLen9/T8wtNi4jJLChNrtFH0su4VOt4cqB/Sg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603233/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603233 \u0000 \u0000\t公司简称：\u0000 大参林\u0000<br />大参林医药集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000241\u0000<br />"},"Highlight":{"Content":["主要健康指标水平进入高收入国家行列，健康公平基本实现，实现《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51395045","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"x+K6OGynOJft/YSBnwuMRQ==","EncryptionKey":"eCtLNk9HeW5PSmZ0L1lTQm53dU1SUT09","Title":"九州通：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"600998","StockTicker":"九州通","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207648356.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=tTo1sqT2GOIYjPek9icc8HRe6noic8VaXOlFQomXoOeldXDSLm1Iqg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600998/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp; \u0000 201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600998 \u0000 \u0000 公司简称：\u0000 九州通\u0000<br />&emsp;&emsp;九州通医药集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000289\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51396202","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"LYzFI5ZEPYn1/jp0ntwNXQ==","EncryptionKey":"TFl6Rkk1WkVQWW4xL2pwMG50d05YUT09","Title":"康恩贝：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"600572","StockTicker":"康恩贝","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207647421.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=ySQ7vzeE/8MYWaLZ3bvDw1sxgc7xL02/NNJ0M2UCEggZHTPgnHfTRg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600572/2020-04-28 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600572\t公司简称：康恩贝<br />浙江康恩贝制药股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />&emsp;&emsp;1、本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。<br />"},"Highlight":{"Content":["@4@27@报告期内，《国务院关于实施健康中国行动的意见》、《健康中国行动（2019－2030年）》，《中共中央国务院关于促进中医药传承创新发展的意见》、《中华人民共和国药品管理法》（2019年修订版）等或法规政策陆续颁布，基本覆盖了药品从研发、生产到市场销售和消费使用等全产业领域，对鼓励支持和规范医药行业健康发展具有深远历史意义。随着“<em>健康中国2030</em>”规划纲要的落地，健康理念正在从以治病为中心向以健康为中心转变，国家对医疗卫生投入将进一步加大，广大人民群众的健康消费也将稳步增长，可以预见，我国医药行业将会迎来崭新的发展阶段，发展空间更为广阔。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51396201","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"drzU6nGA3RY/RTWrj6ky+g==","EncryptionKey":"ZHJ6VTZuR0EzUlkvUlRXcmo2a3krZz09","Title":"康恩贝：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"600572","StockTicker":"康恩贝","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207647422.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=sAq+PucMRR7rP9nX6DveoWpU9Hw3RdI5N1u08t/yrjE9+2rumjyATQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600572/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;浙江康恩贝制药股份有限公司 \u0000 201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600572 \u0000 \u0000 公司简称：\u0000 康恩贝\u0000<br />&emsp;&emsp;浙江康恩贝制药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br /> \u0000<br />"},"Highlight":{"Content":["业领域，对鼓励支持和规范医药行业健康发展具有深远历史意义。随着“<em>健康中国</em>","<em>2030</em>","续出台《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51414477","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"LsFGAT6ei4e6Q6CxLlE4cQ==","EncryptionKey":"THNGR0FUNmVpNGU2UTZDeExsRTRjUT09","Title":"美康生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"300439","StockTicker":"美康生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207645522.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=ttTXG08a+LvO5WLEJPgLlVqfoZMB47d/sv7a6BTGXuyJYX/V7AT2Uw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300439/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;美康生物科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;美康生物科技股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2\u0000020\u0000-\u00000\u000032\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51405218","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"8uxn21cK8qUq8Dr2+1AXHw==","EncryptionKey":"OHV4bjIxY0s4cVVxOERyMisxQVhIdz09","Title":"美康生物：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"300439","StockTicker":"美康生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207645520.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Wp5MvQ92yShikmBOPumsUY5Y6TkyR2R62b6CMpq9buVINGMc0E9Hww==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300439/2020-04-28 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300439 \t证券简称：美康生物\t公告编号：2020-031<br />&emsp;&emsp;美康生物科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@5@81@&emsp;&emsp;一是中长期和短期利好政策结合，助推行业发展。（1）2019年1月28日，国家卫生健康委组织制定了《国家医学中心和国家区域医疗中心设置实施方案》。设置国家医学中心和国家区域医疗中心有利于促进优质医疗资源纵向和横向流动，提高我国整体和各区域医疗服务技术水平。（2）2019年7月15日，健康中国行动推进委员会印发《健康中国行动（2019—2030年）》。为积极应对当前突出健康问题，必须关口前移，采取有效干预措施，努力使群众不生病、少生病，提高生活质量，延长健康寿命。到2030年，全民健康素养水平大幅提升，健康生活方式基本普及，居民主要健康影响因素得到有效控制，因重大慢性病导致的过早死亡率明显降低，人均健康预期寿命得到较大提高，居民主要健康指标水平进入高收入国家行列，健康公平基本实现，实现《“<em>健康中国2030</em>”规划纲要》有关目标。（3）2019年8月1日，国家药监局发布关于扩大医疗器械注册人制度试点工作的通知，加快推进医疗器械产业创新发展。（4）2019年11月29日，国家药监局印发《国家药品监督管理局贯彻落实国务院在自由贸易试验区开展“证照分离”改革全覆盖试点实施方案》的通知，对药品监管领域涉企经营许可有关事项按照实行告知承诺、优化审批服务两种方式推进改革，对“药品生产企业许可”、“第二类、第三类医疗器械生产许可”等23项许可事项采取精简审批材料、优化办事流程、压减审批时限等措施优化审批服务。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51389247","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Db7CKevOFxKg+8MreNzpBg==","EncryptionKey":"RGI3Q0tldk9GeEtnKzhNcmVOenBCZz09","Title":"依米康：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"300249","StockTicker":"依米康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207641053.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=s7gZEydE6wSRiYe62OFXJwqk4vAiNevXK/dETM8bxi3XTnGmby99yw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300249/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;依米康科技集团股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;依米康科技集团股份有限公司\u0000<br />&emsp;&emsp;Yimikang Tech.Group Co., Ltd.\u0000<br />证券代码：\u0000 300249 \u0000 证券简称：依米康 \u0000 \u0000 公告编号：\u0000 2020\u0000-\u0000017\u0000<br />&emsp;&emsp;2019 \u0000 ..."},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51389596","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"2X7nCxURovAMnHR5ZdaQZg==","EncryptionKey":"Mlg3bkN4VVJvdkFNbkhSNVpkYVFaZz09","Title":"奥佳华：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"002614","StockTicker":"奥佳华","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207641545.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=+pL3xWmNBEFYUoxZB4nhyAWUX+5Jj2FVLDWX13vs/OoyopguDvtYGg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002614/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;奥佳华智能健康科技集团股份有限公司 \u0000 \u0000 2019 \u0000年年度报告\u0000<br />&emsp;&emsp;1\u0000<br />奥佳华智能健康科技集团股份有限公司 \u0000 \u0000 2019 \u0000年年度报告\u0000<br />证券代码：\u0000 002614 \u0000\t证券简称：奥佳华 \u0000 \u0000 公告编号：\u0000 20\u000020\u0000-\u000030 \u0000 号\u0000<br />&emsp;&emsp;第一节重要提示、目录和释义\u0000<br /..."},"Highlight":{"Content":["为国家战略，全民健康意识快速提升，中国大健康产业发展日新月异。据《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51386171","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"mWckdqW9dNm7kFMVL5JkXw==","EncryptionKey":"bVdja2RxVzlkTm03a0ZNVkw1SmtYdz09","Title":"以岭药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"002603","StockTicker":"以岭药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207638477.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=BsP5UFYbQaeLuYQZDY4NDuMsJTW8C4Ezi6IyYuyOLyjNoeqr8zCRBw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002603/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;石家庄以岭药业股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />石家庄以岭药业股份有限公司\u0000<br />SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD\u0000<br />&emsp;&emsp;（河北省石家庄市高新技术产业开发区天山大街 \u0000 238 \u0000 号）\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />"},"Highlight":{"Content":["中医药特点的重大制度创新，奠定未来中医药发展基础。《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51446770","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"fK0K/qT1eznxhpi3siZQ0g==","EncryptionKey":"ZkswSy9xVDFlem54aHBpM3NpWlEwZz09","Title":"众生药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"002317","StockTicker":"众生药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207643092.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=RilIRIjQWRFEJ+H74YwvN0LCt69U0IrvwnORGvc98DuDJZJMPmUNLw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002317/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;广东众生药业股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;广东众生\u0000药业股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51446769","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Ec4w8sLYJMyNOV/ILuTqmw==","EncryptionKey":"RWM0dzhzTFlKTXlOT1YvSUx1VHFtdz09","Title":"众生药业：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"002317","StockTicker":"众生药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207643093.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=0E5FLD7eg35IrDpBI/An9Y6xx/9EywQBp1sx6g3jxDXUwZnFHNz2ew==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002317/2020-04-28 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：002317\t证券简称：众生药业\t公告编号：2020-027<br />&emsp;&emsp;广东众生药业股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@21@151@&emsp;&emsp;国务院印发了《“<em>健康中国</em> <em>2030</em>”规划纲要》，党的十九大报告提出“实施健康中国战略”，“健康中国”上升为国家战略，对医药健康产业产生了重大深远的影响，医药行业在宏观政策的引领下发展趋快。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51385248","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"+rigTTlnTT3HjPqhjb7mQA==","EncryptionKey":"K3JpZ1RUbG5UVDNIalBxaGpiN21RQT09","Title":"海王生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-28T00:00:00","StockCode":"000078","StockTicker":"海王生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-28/1207637636.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"零售业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=rpmyBehat5X2Yg7Jo7+2Chift/BFAX35RTycZ8qxj9G0O6pBP7JXkw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000078/2020-04-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;深圳市海王生物工程股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />深圳市海王生物工程股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-91609","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"/5VUSPTOIn4r8Pp+fsLoeQ==","EncryptionKey":"LzVWVVNQVE9JbjRyOFBwK2ZzTG9lUT09","Title":"迈得医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"688310","StockTicker":"迈得医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207605482.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=jJhinQ3qoPjcMPc4FLc0TGvqxdjtQRJXhJMJVSXzve7GgkWNxhy12g==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688310/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688310\t公司简称：迈得医疗<br />迈得医疗工业设备股份有限公司<br />&emsp;&emsp;2019 年年度报告<br />&emsp;&emsp;重要提示<br />一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整，<br />"},"Highlight":{"Content":["@15@163@&emsp;&emsp;②医疗产业关系人民身体健康，关乎民生发展，国家不断从政策上、支出上推动产业发展。2016年国务院印发了《“<em>健康中国2030</em>”规划纲要》，国家对卫生领域的投入将持续增加。据统计，2017年我国卫生费用总支出为51,598.8亿元，相比2013年增加了19,929.85亿元，年均复合增长率达10.26%。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-91610","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"1SPWnmxLyaZEmZ79/CN42Q==","EncryptionKey":"MVNQV25teEx5YVpFbVo3OS9DTjQyUT09","Title":"迈得医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"688310","StockTicker":"迈得医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207605481.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=NNGjQdqvmRLKt1OealcTqN0shas5YuK/JmmeE6jUmo3TP3iqyUVnbw==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688310/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688310 \t公司简称：迈得医疗<br />迈得医疗工业设备股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 重大风险提示<br />"},"Highlight":{"Content":["@9@82@&emsp;&emsp;②医疗产业关系人民身体健康，关乎民生发展，国家不断从政策上、支出上推动产业发展。2016年国务院印发了《“<em>健康中国2030</em>”规划纲要》，国家对卫生领域的投入将持续增加。据统计，2017年我国卫生费用总支出为51,598.8亿元，相比2013年增加了19,929.85亿元，年均复合增长率达10.26%。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51315114","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"znoVe0VPALfXh+N9m86egA==","EncryptionKey":"em5vVmUwVlBBTGZYaCtOOW04NmVnQT09","Title":"麦迪科技：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"603990","StockTicker":"麦迪科技","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207614428.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=XnElpJ3k5OwPg67cklW1ny5ecSfG5fUO+D+pkXc3OxVYMh4+0kJdlg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603990/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603990 \u0000 \u0000 公司简称：\u0000 麦迪科技\u0000<br />苏州麦迪斯顿医疗科技股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000294\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","大会和《“<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51315116","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"37v9gRWgTRLbrfRxQw4+7w==","EncryptionKey":"Mzd2OWdSV2dUUkxicmZSeFF3NCs3dz09","Title":"麦迪科技：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"603990","StockTicker":"麦迪科技","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207614439.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=bRTDiKk4DFXHx41MIMTb9Gj8cqgmTnqhyKTf8QQodymtZkI3m+URvw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603990/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：603990\t公司简称：麦迪科技<br />苏州麦迪斯顿医疗科技股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年..."},"Highlight":{"Content":["@5@49@&emsp;&emsp;由中共中央、国务院于 2016 年 10 月 25 日印发并实施的《“<em>健康中国</em> <em>2030</em>”规划纲要》将医疗健康信息化作为发展战略之一，明确提出要完善人口健康信息服务体系建设和推进健康医疗大数据应用，且将其作为今后15年推进健康中国建设的行动纲领。为贯彻落实全国卫生与健康大会和《“<em>健康中国</em> <em>2030</em>”规划纲要》部署，加快推动健康产业发展，促进形成内涵丰富、结构合理的健康产业体系，2019年9月30日国家发改委联合国家卫健委、中医药管理局、国家药监局、国家医保局等 21 部委共同印发了《促进健康产业高质量发展行动纲要 （2019-2022 年）》，强调加强部门协调联动，大力发展健康产业，实施健康中国战略，其中将“互联网+医疗健康”提升工程为十项重大工程之一，对建设全民健康信息平台、运用健康医疗大数据、加快发展“互联网+医疗”等方面提出了明确的要求。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51311934","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"sx89yTN/UsuteLZJjImpKQ==","EncryptionKey":"c3g4OXlUTi9Vc3V0ZUxaSmpJbXBLUT09","Title":"香飘飘：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"603711","StockTicker":"香飘飘","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207611601.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"酒、饮料和精制茶制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=KLEl5C7TtJ3wPKxAlo7i8mzi3ecYEN/zVMNeQP1rub7Z11vnjHhKLg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603711/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603711 \u0000 \u0000 公司简称：\u0000 香飘飘\u0000<br />&emsp;&emsp;香飘飘食品股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000178\u0000<br />"},"Highlight":{"Content":["范。为贯彻落实《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51306096","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"WRVJ3x67ba749k6k0FFOVg==","EncryptionKey":"V1JWSjN4NjdiYTc0OWs2azBGRk9WZz09","Title":"莎普爱思：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"603168","StockTicker":"莎普爱思","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207600226.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=3u1UuSFM4lz62UM4tPf6J7wEhn1GnKm9oljOeEK9oEsVnlRBNR9/eA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603168/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：\u0000 603168 \u0000 \u0000 公司简称：\u0000 莎普爱思\u0000<br />浙江莎普爱思药业股份有限公司 \u0000<br />&emsp;&emsp;6\u000003168 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;二零二零年四月二十\u0000五\u0000日\u0000<br />"},"Highlight":{"Content":["<em>2030</em>","<em>健康中国</em>","<em>2030</em>”","体，构成健康中国战略和<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51310279","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ejm7iDDphjhxgJeUdKlc0g==","EncryptionKey":"ZWptN2lERHBoamh4Z0plVWRLbGMwZz09","Title":"ST运盛：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"600767","StockTicker":"ST运盛","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207610107.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=04mHDHbh9aUIQaXPM4AtFi3WrHTCqDuB5ZS4Jvdg+yZ3KKUVoQKTaQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600767/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600767\t公司简称：ST运盛<br />运盛（上海）医疗科技股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 重大风险提示<br />"},"Highlight":{"Content":["@5@44@&emsp;&emsp;《中医药发展战略规划纲要（2016—2030年）》提出，到2020年，实现人人基本享有中医药服务，中医医疗、保健、科研、教育、产业、文化各领域得到全面协调发展。《“<em>健康中国</em> <em>2030</em>”规划纲要》要求，充分发挥中医药独特优势、优化多元办医格局、推进健康医疗大数据应用。中医医疗服务得到了政府的大力支持，社会效益逐步凸显，未来发展潜力巨大。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51310278","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"9Nyht8t0rl1RyTW+WdbT1A==","EncryptionKey":"OU55aHQ4dDBybDFSeVRXK1dkYlQxQT09","Title":"ST运盛：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"600767","StockTicker":"ST运盛","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207610108.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Q9pedESVl9KBBkFs5VQCPaBUb6MC3xZW0JkEAB5QNLTcl7ihhhrsNg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600767/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600767 \u0000 \u0000\t公司简称：\u0000 ST \u0000 运盛\u0000<br />运盛（上海）医疗科技股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000178\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51309983","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"8LU+uBfuWfJKkq9hXQ7Qbg==","EncryptionKey":"OExVK3VCZnVXZkpLa3E5aFhRN1FiZz09","Title":"片仔癀：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"600436","StockTicker":"片仔癀","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207609696.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=SA0ZmEKiQwreg0joxJ33CYWqTjOt1EnB2R/cwNLI1fOjetudrprWoQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600436/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600436 \u0000 \u0000 公司简称：\u0000 片仔癀 \u0000<br />漳州片仔癀药业股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000267\u0000<br />"},"Highlight":{"Content":["伴随着《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51309984","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"dZh5Pd3W9H66zIDoaDMaBw==","EncryptionKey":"ZFpoNVBkM1c5SDY2eklEb2FETWFCdz09","Title":"片仔癀：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"600436","StockTicker":"片仔癀","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207609695.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=5T0B3Gw8B1euD8WQ9gj82psOGhWRB/+ftMgdkSyw0SKbSkLuwutciQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600436/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600436\t公司简称：片仔癀<br />漳州片仔癀药业股份有限公司<br />2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。<br />"},"Highlight":{"Content":["@6@48@&emsp;&emsp;伴随着《<em>健康中国</em> <em>2030</em> 规划纲要》《中国防治慢性病中长期规划（2017—2025）》等文件的落地，未来的医学模式将由疾病治疗向健康管理转变，由生物医学向“生物－心理－社会”相结合的新医学模式转变，这与中医药的绿色健康理念、天人合一的观念一脉相承。针对我国当前面临着人口老龄化进程加剧、亚健康人群及慢性病患者基数大幅增加的问题，随着中医药服务发展的顶层设计、相应网络建设逐步完善及全民健康生活理念的转变，中医药医疗服务在发挥保障人民健康方面大有可为。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51314875","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"FqTJYr6Wu33Brv5jat62Lg==","EncryptionKey":"RnFUSllyNld1MzNCcnY1amF0NjJMZz09","Title":"华大基因：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300676","StockTicker":"华大基因","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207611777.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专业技术服务业","ParentIndustry":"科学研究和技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=veIxA3HjO6V9uQDJBHf8tEr6UP0URXzOjraT5qG0hlnoVKMb2KnOMA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300676/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300676 \t证券简称：华大基因\t公告编号：2020-039<br />&emsp;&emsp;深圳华大基因股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />公司全体董事亲自出席了审议本次年报的董事会会议<br />"},"Highlight":{"Content":["@19@142@&emsp;&emsp;报告期内，公司积极履行社会责任，通过出生缺陷防控、地贫防控、聋病防控等民生工程和健康关爱计划，让精准医学普惠更多民众，助力“<em>健康中国2030</em>”的实施落地。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51314876","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"YETdTTtjPfSx9XVRCZ8skA==","EncryptionKey":"WUVUZFRUdGpQZlN4OVhWUkNaOHNrQT09","Title":"华大基因：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300676","StockTicker":"华大基因","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207611776.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专业技术服务业","ParentIndustry":"科学研究和技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=tZiwMwqC5Aq2wB0ZYNr3anC/u0gedt8bIT+rnaoMpyQMYdIA4hT4Xw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300676/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;深圳华大基因股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />深圳华大基因股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>","<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=tZiwMwqC5Aq2wB0ZYNr3anC/u0gedt8bIT+rnaoMpyQMYdIA4hT4Xw==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51324682","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Ojblhy3e5KZ0PMSeZrXQug==","EncryptionKey":"T2pibGh5M2U1S1owUE1TZVpyWFF1Zz09","Title":"乐心医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300562","StockTicker":"乐心医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207612510.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=QPJ7O8DRG3rKo4fV9oPbFydFa1BIwuwcIjVTPOhWR6oHVtVgkS7lpQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300562/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;广东乐心医疗电子股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />广东乐心医疗电子股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000033\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=QPJ7O8DRG3rKo4fV9oPbFydFa1BIwuwcIjVTPOhWR6oHVtVgkS7lpQ==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51324712","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"3uzdFhQp2AFBo/YFr4tYTg==","EncryptionKey":"M3V6ZEZoUXAyQUZCby9ZRnI0dFlUZz09","Title":"乐心医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300562","StockTicker":"乐心医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207612505.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=nlsHAIGuqbA7rfyF8bnUK3d769k63adLo4C7oXjY10buo17EHaMukQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300562/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300562\t证券简称：乐心医疗\t公告编号：2020-032<br />&emsp;&emsp;广东乐心医疗电子股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />&emsp;&emsp;董事、监事、..."},"Highlight":{"Content":["@3@34@&emsp;&emsp;国家利好政策频发强有力支持健康IoT行业发展。老龄化及不良习惯诱导慢性病患病率不断升高，多省市医疗保险、医保基金将出现缺口，医疗体系面临巨大压力。在此背景下，国家中共中央、国务院印发了《“<em>健康中国2030</em>”规划纲要》，“健康中国”上升为国家战略，随着《健康中国行动（2019—2030年）》等一系列健康中国行动配套政策落地，明确提出支持推进可穿戴设备、智能健康电子产品和健康医疗移动应用服务等发展。强有力的产业政策支持助力行业发展。","@4@47@&emsp;&emsp;《“<em>健康中国2030</em>”规划纲要》规划了健康中国的战略目标和重要指标，并预计我国医疗健康服务业总规模将在2020年超过8万亿，在2030年达到16万亿元。为全面贯彻落实《“<em>健康中国2030</em>”规划纲要》，2019年7月，国务院印发《国务院关于实施健康中国行动的意见》，国务院办公厅印发《健康中国行动组织实施和考核方案》，国家层面印发《健康中国行动（2019—2030年）》，以上健康中国行动相关文件从政府、社会、个人三个层面协同推进，从以“疾病”为中心向以“健康”为中心转变，从注重“治已病”向注重“治未病”转变，从依靠卫生健康系统向社会整体联动转变。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51325009","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"tWCghthhqT9LR+eKwQWOGw==","EncryptionKey":"dFdDZ2h0aGhxVDlMUitlS3dRV09Hdz09","Title":"和佳医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300273","StockTicker":"和佳医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207611732.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Z98gArAeKpVzxv6wy8bMrqG43KOTiu9LQzXCtdWpWMbuoOMpKQv53g==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300273/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;珠海和佳医疗设备股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;珠海和佳医疗设备股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1 \u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51325018","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"BRdr5oNEhQF+u0UU7S9X6A==","EncryptionKey":"QlJkcjVvTkVoUUYrdTBVVTdTOVg2QT09","Title":"和佳医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300273","StockTicker":"和佳医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207611734.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=TdRxpEsCdtvbSr8MRUo+OVABPuHeOyjnQml49rlyHNcA3jlVMOSDvg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300273/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300273                              证券简称：和佳医疗\t公告编号：2020-039 <br />&emsp;&emsp;珠海和佳医疗设备股份有限公司 2019 年年度报告摘要<br />&emsp;&emsp;一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到..."},"Highlight":{"Content":["@2@26@&emsp;&emsp;随着社会经济的发展和“健康中国”战略的规划实施，国家持续加强医改力度和医疗投入，医疗健康产业已经成为国家支柱型战略产业。国家政策的支持、居民消费能力和健康意识提升、人口老龄化加速以及医疗服务消费结构升级促进了国内医疗健康服务需求的快速增长，医疗与健康产业市场总量持续扩大，根据《“<em>健康中国2030</em>”规划纲要》规划，2030年我国健康服务产业规模将达到16万亿元以上。“十三五”期间，国家政策导向将继续支持医疗健康行业，并持续推动整个产业的快速发展。国家政策支持与市场需求增长双因素将驱动医疗市场的规模进一步扩大，医疗器械和医疗服务行业将迎来新的发展契机。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51307042","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"++RFcBekV7RD8fa6BQXjQQ==","EncryptionKey":"KytSRmNCZWtWN1JEOGZhNkJRWGpRUT09","Title":"冠昊生物：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300238","StockTicker":"冠昊生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207600902.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Kn4q+15S5QonvQSfqXzdJ1IdYUkj6JGDyTcugMInZvM101GANenM+Q==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300238/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300238\t证券简称：冠昊生物\t公告编号：2020-035<br />&emsp;&emsp;冠昊生物科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />&emsp;&emsp;本报告涉及的发展..."},"Highlight":{"Content":["@3@45@&emsp;&emsp;2016年7月，国务院发布《“十三五”国家科技创新规划》（国发[2016]43号），针对生物医用材料，提出“应重点布局可组织诱导生物医用材料、组织工程产品、新一代植介入医疗器械、人工器官等重大战略性产品，提升医用级基础原材料的标准，构建新一代生物医用材料产品创新链，提升生物医用材料产业竞争力”；《国家中长期科学和技术发展规划纲要（2006-2020）》将“先进医疗设备与生物医用材料”作为人口与健康的优先发展主题，要重点研究组织工程等技术，开发人体组织器官替代等新型生物医用材料。2016年8月国务院发布《“<em>健康中国2030</em>”规划纲要》，作为今后15年推进健康中国建设的行动纲领，医疗器械行业在其中“优化健康服务”、“完善健康保障”、“发展健康产业”等多领域都有极具前景并充满挑战性的发展机会。2018年1月，广州市政府常务会议通过了《广州市加快IAB产业发展五年行动计划（2018-2022年）》，其中生物医药即是三大战略新兴产业之一，而生物材料作为生物医药中的最重要组成之一，也是广州市的优势产业，符合广州市政府未来5-10年重点支持和发展的产业方向。目前我国生物再生材料仍处于发展的起步阶段，与国外先进水平相比仍存在较大差距，但上述政策将有效促进我国生物再生材料行业的健康、快速发展。","@4@56@&emsp;&emsp;一直以来，我国高度重视干细胞领域，《“<em>健康中国2030</em>”规划纲要》与《“十三五”国家战略性新兴产业发展规划》《“十三五”生物技术创新专项规划》都将干细胞写进战略部署中。明确提出发展干细胞产业，提供资金和政策支持，对干细胞基础科研和临床前转化、临床研究、药物研发提供引导作用。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51307065","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"xMc+77c44AReVppyg9/xnA==","EncryptionKey":"eE1jKzc3YzQ0QVJlVnBweWc5L3huQT09","Title":"冠昊生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300238","StockTicker":"冠昊生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207600907.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=oXZ4fp1j1gJMFhSwNXaUy3aNNwgH0X7UMuCX2WhSiOwf55rB4HdXGg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300238/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;冠昊生物科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />冠昊生物科技股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51314445","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"sUxKRNRoHt6A+y1ZGlUpbw==","EncryptionKey":"c1V4S1JOUm9IdDZBK3kxWkdsVXBidz09","Title":"盈康生命：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300143","StockTicker":"盈康生命","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207609193.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=DXbN2oHljZWpfJsxN4/+GHETowFA+lwJYHfBPjvVfuoWeaRQjtN9tg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300143/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"盈康生命科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;盈康生命科技股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />1\u0000<br />"},"Highlight":{"Content":["技术、养老助残技术等关键技术。《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51314441","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"oFY4oSWwILxP3JfgpbZA0g==","EncryptionKey":"b0ZZNG9TV3dJTHhQM0pmZ3BiWkEwZz09","Title":"盈康生命：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"300143","StockTicker":"盈康生命","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207609159.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=iFha6Hf0/69oJdkJ6CUD6DpoVWYZbTjoZpHoCRJZ/ufQT5jInxwISw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300143/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300143 \t证券简称：盈康生命\t公告编号：2020-042<br />&emsp;&emsp;盈康生命科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />&emsp;&emsp;本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />&emsp;&emsp;所有董事均已出..."},"Highlight":{"Content":["@8@111@&emsp;&emsp;《中国制造2025》明确把新材料、生物医药及高性能医疗器械作为重点发展的十大领域之一，提出提高医疗器械的创新能力和产业化水平，逐步摆脱高端医疗器械依赖进口的局面。《“十三五”国家科技创新规划》特别强调“十三五”时期将重点发展数字诊疗装备、体外诊断产品、健康促进关键技术、健康服务技术、养老助残技术等关键技术。《“<em>健康中国2030</em>”规划纲要》提出，未来15年，将深化医疗器械流通体制改革、强化医疗器械安全监管、加强高端医疗器械创新能力建设、推进医疗器械国产化。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51313201","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"v+2qH+TuKiY6K6TC8nELEQ==","EncryptionKey":"disycUgrVHVLaVk2SzZUQzhuRUxFUT09","Title":"好想你：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"002582","StockTicker":"好想你","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207607568.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"农副食品加工业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=k/zvGjtOJH0/cX2OVM7Anos3uZBUt4Mv4t4yFSy5fK+E1SjG+OLo8w==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002582/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;好想你健康食品股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />好想你健康食品股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["关于抓好“三农”领域重点工作确保如期实现全面小康的意见》、《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51312524","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"TWGPfi9BcfHFVJwGS0xjLg==","EncryptionKey":"VFdHUGZpOUJjZkhGVkp3R1MweGpMZz09","Title":"国新健康：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"000503","StockTicker":"国新健康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207606983.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"互联网和相关服务","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=1EEHmoEVybSYUDFlnovOECx9IumomAle2UeQDwu2BCR4FVpfli7wLA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000503/2020-04-25 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：000503 \t证券简称：国新健康\t公告编号：2020-09<br />国新健康保障服务集团股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />"},"Highlight":{"Content":["@7@100@&emsp;&emsp;2019年，在公司董事会的坚强领导下，国新健康紧紧围绕国家“<em>健康中国2030</em>”战略及 “三医联动”改革要求，持续深耕医保基金综合管理服务、医疗质量安全服务、药械监管服务领域，积极打造专业、独立的第三方健康保障服务体系。公司坚持战略引领，围绕年度经营目标，建立健全项目管理体系及营销体系，持续增强运营支撑能力建设，优化完善产品体系，取得了一系列阶段性成果。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51312527","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"5SMrr+G5iFA4/bimGIur/g==","EncryptionKey":"NVNNcnIrRzVpRkE0L2JpbUdJdXIvZz09","Title":"国新健康：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-25T00:00:00","StockCode":"000503","StockTicker":"国新健康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-25/1207607005.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"互联网和相关服务","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=guxF6YtDuxmJN36Kh8Fx72ikLuwyGAqngjXBRS/TNG36d7JU7Z0Cyg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000503/2020-04-25 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;国新健康保障服务集团股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;国新健康保障服务集团股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000 \u0000<br />&emsp;&emsp; \u0000<br /> \u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51281671","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"K2RUduJieffmQmrmCMSGew==","EncryptionKey":"SzJSVWR1SmllZmZtUW1ybUNNU0dldz09","Title":"通策医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-24T00:00:00","StockCode":"600763","StockTicker":"通策医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-24/1207586177.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"卫生","ParentIndustry":"卫生和社会工作","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=rHlM1y/Ad1ZGqCgsITFh//jF13MoNVupEx2YmvXA5qSONVJM8+F4hg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600763/2020-04-24 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600763 \u0000 \u0000 公司简称：\u0000 通策医疗\u0000<br />&emsp;&emsp;通策医疗股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1\u0000/\u0000194\u0000<br />"},"Highlight":{"Content":["）》，提出贯彻落实《<em>健康中国</em>","<em>2030</em>","亿人。国务院发布《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51286605","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"qVrEU8FKH/nEVGOeVDGB6A==","EncryptionKey":"cVZyRVU4RktIL25FVkdPZVZER0I2QT09","Title":"仙乐健康：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-24T00:00:00","StockCode":"300791","StockTicker":"仙乐健康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-24/1207589307.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=jd+Vl1QYfyWPhcmEKTTuuSNt9+BLW/Pc3BLXFN3q4aqAOeuLVl31mw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300791/2020-04-24 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp; \u0000 仙乐健康科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />证券代码：\u0000 300791 \u0000\t证券简称：仙乐健康 \u0000\t公告编码\u0000：\u0000 2020\u0000-\u0000016\u0000<br />&emsp;&emsp;仙乐健康科技股份有限公司 \u0000<br />&emsp;&emsp;SIRIO PHARMA CO., LTD.\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告..."},"Highlight":{"Content":["年，政府出台《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51284606","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"hIBxba2KDHESr5AJHnw3uw==","EncryptionKey":"aElCeGJhMktESEVTcjVBSkhudzN1dz09","Title":"融捷健康：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-24T00:00:00","StockCode":"300247","StockTicker":"融捷健康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-24/1207587074.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"电气机械和器材制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Ud6zMTXqCiLG7hfaA+GRMaFik4Cdq00jUouMGLBigIpH/3oIw3opAQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300247/2020-04-24 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;融捷健康科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />融捷健康科技股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51284610","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"UTTpuj9ONnPIyDJTe/Mo/Q==","EncryptionKey":"VVRUcHVqOU9OblBJeURKVGUvTW8vUT09","Title":"融捷健康：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-24T00:00:00","StockCode":"300247","StockTicker":"融捷健康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-24/1207587069.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"电气机械和器材制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=i2NLfS2o/hBuUppniyTSj5GZTq5d++jWnnpLhAMXKf753xKzDyV3xA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300247/2020-04-24 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300247 \t证券简称：融捷健康\t公告编号：2020-020<br />&emsp;&emsp;融捷健康科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@9@52@&emsp;&emsp;（1）2016年是中国健康产业跨越式发展的政策元年。2016年10月，党的十八届六中全会大提出了健康国家建设的战略目标，把“健康中国”建设上升为国家战略，把健康置于优先发展的位置，提出了“没有全民健康，就没有全面小康”。并制定了《“<em>健康中国2030</em>”规划纲要》，明确提出“健康服务业”总规模于2020年、2030年要超过8万亿元和16万亿元。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51285718","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"DBLbXKw38T/sPZjRDp6IGw==","EncryptionKey":"REJMYlhLdzM4VC9zUFpqUkRwNklHdz09","Title":"量子生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-24T00:00:00","StockCode":"300149","StockTicker":"量子生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-24/1207588438.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"研究和试验发展","ParentIndustry":"科学研究和技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=/bji+zHAq3ktsfX2hOGx2ZHpkF4bivdxWqciPZ3Gk/xTdkg6rLd9dQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300149/2020-04-24 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"量子高科（中国）生物股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />量子高科（中国）生物股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;- \u00001 \u0000-\u0000<br />"},"Highlight":{"Content":["@38@419@&emsp;&emsp;从《十三五规划纲要》明确提出健康中国战略到《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51279998","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"mhmmt/Bjd3riWJMgFu6wxw==","EncryptionKey":"bWhtbXQvQmpkM3JpV0pNZ0Z1Nnd4dz09","Title":"佛慈制药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-24T00:00:00","StockCode":"002644","StockTicker":"佛慈制药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-24/1207583808.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=bSwhrkoaFFIz8W6yesKcf1y1M9vPnIqOuqGZNeXIZP6oEGX+xCR+cQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002644/2020-04-24 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;兰州佛慈制药股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />兰州佛慈制药股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 4 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51264078","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"fx48voCkwoHdfX4TRrwCwQ==","EncryptionKey":"Zng0OHZvQ2t3b0hkZlg0VFJyd0N3UT09","Title":"柳药股份：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-23T00:00:00","StockCode":"603368","StockTicker":"柳药股份","Url":"http://static.cninfo.com.cn/finalpage/2020-04-23/1207559016.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=A91CXTd8+/nkqYDC/WThdSclIFbHLjL9tSsEv1jCel6ttnbJ7eehgA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603368/2020-04-23 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：603368\t公司简称：柳药股份转债代码：113563\t转债简称：柳药转债<br />&emsp;&emsp;广西柳州医药股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一、重要提示<br />1、本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文..."},"Highlight":{"Content":["@5@37@&emsp;&emsp;随着互联网信息技术的发展，通过互联网技术提升医疗卫生现代化管理水平，优化资源配置，提高服务效率，降低服务成本，满足人民群众日益增长的医疗卫生健康需求成为新的发展课题。依据《“<em>健康中国2030</em>”规划纲要》、《国务院关于积极推进“互联网+”行动的指导意见》文件精神，国务院办公厅下发了《关于促进“互联网+医疗健康”发展的意见》，提出发展“互联网+”医疗服务、完善“互联网+”药品供应保障服务、推进“互联网+”医疗保障结算服务等一系列意见，鼓励医疗信息的互联互通、数据共享。在2019年8月，国家医保局印发了《关于完善“互联网+”医疗服务价格和医保支付政策的指导意见》，要求完善“互联网+”医疗服务价格项目管理，健全“互联网+”医疗服务价格形成机制，明确“互联网+”医疗服务的医保支付政策。一系列政策的推行，推动在线诊疗、购药云服务的发展，医保支付、处方药销售、处方信息共享等问题正在逐步探索解决，互联网技术应用下医药行业新业态正在形成。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]}],"GroupKey":null,"GroupHits":[],"Aggregations":[{"AggKey":"companyCount","AggName":null,"Items":[{"N":"total","C":111,"M":0,"JsonTag":null}],"ItemList":[]},{"AggKey":"company","AggName":null,"Items":[{"N":"300147 香雪制药","C":5,"M":0,"JsonTag":null},{"N":"600257 大湖股份","C":3,"M":0,"JsonTag":null},{"N":"000503 国新健康","C":2,"M":0,"JsonTag":null},{"N":"000516 国际医学","C":2,"M":0,"JsonTag":null},{"N":"000590 启迪古汉","C":2,"M":0,"JsonTag":null},{"N":"000931 中关村","C":2,"M":0,"JsonTag":null},{"N":"002022 科华生物","C":2,"M":0,"JsonTag":null},{"N":"002044 美年健康","C":2,"M":0,"JsonTag":null},{"N":"002107 沃华医药","C":2,"M":0,"JsonTag":null},{"N":"002317 众生药业","C":2,"M":0,"JsonTag":null},{"N":"002566 益盛药业","C":2,"M":0,"JsonTag":null},{"N":"002589 瑞康医药","C":2,"M":0,"JsonTag":null},{"N":"002864 盘龙药业","C":2,"M":0,"JsonTag":null},{"N":"300030 阳普医疗","C":2,"M":0,"JsonTag":null},{"N":"300143 盈康生命","C":2,"M":0,"JsonTag":null},{"N":"300146 汤臣倍健","C":2,"M":0,"JsonTag":null},{"N":"300238 冠昊生物","C":2,"M":0,"JsonTag":null},{"N":"300247 融捷健康","C":2,"M":0,"JsonTag":null},{"N":"300273 和佳医疗","C":2,"M":0,"JsonTag":null},{"N":"300289 利德曼","C":2,"M":0,"JsonTag":null},{"N":"300439 美康生物","C":2,"M":0,"JsonTag":null},{"N":"300451 创业慧康","C":2,"M":0,"JsonTag":null},{"N":"300453 三鑫医疗","C":2,"M":0,"JsonTag":null},{"N":"300534 陇神戎发","C":2,"M":0,"JsonTag":null},{"N":"300562 乐心医疗","C":2,"M":0,"JsonTag":null},{"N":"300676 华大基因","C":2,"M":0,"JsonTag":null},{"N":"300765 新诺威","C":2,"M":0,"JsonTag":null},{"N":"600090 *ST济堂","C":2,"M":0,"JsonTag":null},{"N":"600381 青海春天","C":2,"M":0,"JsonTag":null},{"N":"600422 昆药集团","C":2,"M":0,"JsonTag":null},{"N":"600436 片仔癀","C":2,"M":0,"JsonTag":null},{"N":"600568 *ST中珠","C":2,"M":0,"JsonTag":null},{"N":"600572 康恩贝","C":2,"M":0,"JsonTag":null},{"N":"600587 新华医疗","C":2,"M":0,"JsonTag":null},{"N":"600645 中源协和","C":2,"M":0,"JsonTag":null},{"N":"600763 通策医疗","C":2,"M":0,"JsonTag":null},{"N":"600767 ST运盛","C":2,"M":0,"JsonTag":null},{"N":"600771 广誉远","C":2,"M":0,"JsonTag":null},{"N":"603127 昭衍新药","C":2,"M":0,"JsonTag":null},{"N":"603368 柳药股份","C":2,"M":0,"JsonTag":null},{"N":"603567 珍宝岛","C":2,"M":0,"JsonTag":null},{"N":"603669 灵康药业","C":2,"M":0,"JsonTag":null},{"N":"603676 卫信康","C":2,"M":0,"JsonTag":null},{"N":"603719 良品铺子","C":2,"M":0,"JsonTag":null},{"N":"603939 益丰药房","C":2,"M":0,"JsonTag":null},{"N":"603990 麦迪科技","C":2,"M":0,"JsonTag":null},{"N":"603998 方盛制药","C":2,"M":0,"JsonTag":null},{"N":"688089 嘉必优","C":2,"M":0,"JsonTag":null},{"N":"688310 迈得医疗","C":2,"M":0,"JsonTag":null},{"N":"000009 中国宝安","C":1,"M":0,"JsonTag":null},{"N":"000078 海王生物","C":1,"M":0,"JsonTag":null},{"N":"000639 西王食品","C":1,"M":0,"JsonTag":null},{"N":"000705 浙江震元","C":1,"M":0,"JsonTag":null},{"N":"000989 九芝堂","C":1,"M":0,"JsonTag":null},{"N":"000990 诚志股份","C":1,"M":0,"JsonTag":null},{"N":"000999 华润三九","C":1,"M":0,"JsonTag":null},{"N":"002016 世荣兆业","C":1,"M":0,"JsonTag":null},{"N":"002093 国脉科技","C":1,"M":0,"JsonTag":null},{"N":"002166 莱茵生物","C":1,"M":0,"JsonTag":null},{"N":"002262 恩华药业","C":1,"M":0,"JsonTag":null},{"N":"002294 信立泰","C":1,"M":0,"JsonTag":null},{"N":"002411 延安必康","C":1,"M":0,"JsonTag":null},{"N":"002424 贵州百灵","C":1,"M":0,"JsonTag":null},{"N":"002433 太安堂","C":1,"M":0,"JsonTag":null},{"N":"002582 好想你","C":1,"M":0,"JsonTag":null},{"N":"002603 以岭药业","C":1,"M":0,"JsonTag":null},{"N":"002614 奥佳华","C":1,"M":0,"JsonTag":null},{"N":"002644 佛慈制药","C":1,"M":0,"JsonTag":null},{"N":"300003 乐普医疗","C":1,"M":0,"JsonTag":null},{"N":"300009 安科生物","C":1,"M":0,"JsonTag":null},{"N":"300096 易联众","C":1,"M":0,"JsonTag":null},{"N":"300122 智飞生物","C":1,"M":0,"JsonTag":null},{"N":"300149 量子生物","C":1,"M":0,"JsonTag":null},{"N":"300216 千山退","C":1,"M":0,"JsonTag":null},{"N":"300239 东宝生物","C":1,"M":0,"JsonTag":null},{"N":"300249 依米康","C":1,"M":0,"JsonTag":null},{"N":"300253 卫宁健康","C":1,"M":0,"JsonTag":null},{"N":"300298 三诺生物","C":1,"M":0,"JsonTag":null},{"N":"300314 戴维医疗","C":1,"M":0,"JsonTag":null},{"N":"300396 迪瑞医疗","C":1,"M":0,"JsonTag":null},{"N":"300479 神思电子","C":1,"M":0,"JsonTag":null},{"N":"300605 恒锋信息","C":1,"M":0,"JsonTag":null},{"N":"300639 凯普生物","C":1,"M":0,"JsonTag":null},{"N":"300791 仙乐健康","C":1,"M":0,"JsonTag":null},{"N":"600080 ST金花","C":1,"M":0,"JsonTag":null},{"N":"600085 同仁堂","C":1,"M":0,"JsonTag":null},{"N":"600161 天坛生物","C":1,"M":0,"JsonTag":null},{"N":"600222 太龙药业","C":1,"M":0,"JsonTag":null},{"N":"600223 鲁商发展","C":1,"M":0,"JsonTag":null},{"N":"600272 开开实业","C":1,"M":0,"JsonTag":null},{"N":"600285 羚锐制药","C":1,"M":0,"JsonTag":null},{"N":"600380 健康元","C":1,"M":0,"JsonTag":null},{"N":"600479 千金药业","C":1,"M":0,"JsonTag":null},{"N":"600521 华海药业","C":1,"M":0,"JsonTag":null},{"N":"600530 *ST交昂","C":1,"M":0,"JsonTag":null},{"N":"600538 国发股份","C":1,"M":0,"JsonTag":null},{"N":"600750 江中药业","C":1,"M":0,"JsonTag":null},{"N":"600781 *ST辅仁","C":1,"M":0,"JsonTag":null},{"N":"600976 健民集团","C":1,"M":0,"JsonTag":null},{"N":"600998 九州通","C":1,"M":0,"JsonTag":null},{"N":"601601 中国太保","C":1,"M":0,"JsonTag":null},{"N":"603139 康惠制药","C":1,"M":0,"JsonTag":null},{"N":"603168 莎普爱思","C":1,"M":0,"JsonTag":null},{"N":"603233 大参林","C":1,"M":0,"JsonTag":null},{"N":"603711 香飘飘","C":1,"M":0,"JsonTag":null},{"N":"603739 蔚蓝生物","C":1,"M":0,"JsonTag":null},{"N":"603858 步长制药","C":1,"M":0,"JsonTag":null},{"N":"603896 寿仙谷","C":1,"M":0,"JsonTag":null},{"N":"603987 康德莱","C":1,"M":0,"JsonTag":null},{"N":"688016 心脉医疗","C":1,"M":0,"JsonTag":null},{"N":"688029 南微医学","C":1,"M":0,"JsonTag":null}],"ItemList":[]}],"HighlightFilters":[{"Keyword":"健康中国2030","IsApplied":false}],"TitleHighlights":[],"ContentHighlights":[],"IpoItems":[],"Message":null,"NickName":null,"PaymentStatus":"1","SubscriptionLimit":"20","CanPay":true,"ExpireTime":"2021-08-29","ResponseCode":100,"ResponseMessage":"","Token":"nmRnY1j%2bCGXKCM4bM4TTn3jQHDvW7eGIToGnu4ZfJe7o87Tw1S6SoYeBvRf7P4zvFXODclaHtVxIRE7b0lMXAdV6YpyuqxpGH84D1n0f2sR6vD%2bBGy45OvR6KoTmHezOaKkH6pr2ZE6g%2fpE%2bXsF1WQ%3d%3d","CommonSession":null}